<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Biol</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Biol</journal-id><journal-id journal-id-type="publisher-id">pbio</journal-id><journal-id journal-id-type="pmc">plosbiol</journal-id><journal-title-group><journal-title>PLoS Biology</journal-title></journal-title-group><issn pub-type="ppub">1544-9173</issn><issn pub-type="epub">1545-7885</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">14966532</article-id><article-id pub-id-type="pmc">340941</article-id><article-id pub-id-type="doi">10.1371/journal.pbio.0020030</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Cell Biology</subject><subject>Development</subject><subject>Evolution</subject></subj-group><subj-group subj-group-type="System Taxonomy"><subject>Danio (Zebrafish)</subject><subject>Xenopus</subject><subject>Mus (Mouse)</subject></subj-group></article-categories><title-group><article-title>Lefty Blocks a Subset of TGF&#x003b2; Signals by Antagonizing EGF-CFC Coreceptors</article-title><alt-title alt-title-type="running-head">TGF&#x003b2; Signaling Determinants</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cheng</surname><given-names>Simon K</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Olale</surname><given-names>Felix</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Brivanlou</surname><given-names>Ali H</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Schier</surname><given-names>Alexander F</given-names></name><email>schier@saturn.med.nyu.edu</email><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff1"><bold>1</bold><institution>Developmental Genetics Program, Skirball Institute of Biomolecular Medicine</institution><addr-line>and Department of Cell Biology, New York University School of Medicine, New York, New York</addr-line><country>United States of America</country></aff><aff id="aff2"><bold>2</bold><institution>Laboratory of Molecular Vertebrate Embryology, The Rockefeller University</institution><addr-line>New York, New York</addr-line><country>United States of America</country></aff><pub-date pub-type="ppub"><month>2</month><year>2004</year></pub-date><pub-date pub-type="epub"><day>17</day><month>2</month><year>2004</year></pub-date><pub-date pub-type="pmc-release"><day>17</day><month>2</month><year>2004</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>2</volume><issue>2</issue><elocation-id>e30</elocation-id><history><date date-type="received"><day>16</day><month>9</month><year>2003</year></date><date date-type="accepted"><day>24</day><month>11</month><year>2003</year></date></history><permissions><copyright-statement>Copyright: &#x000a9;2004 Cheng et al.</copyright-statement><copyright-year>2004</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><related-article id="d35e151" related-article-type="companion" ext-link-type="doi" xlink:href="10.1371/journal.pbio.0020061" xlink:title="synopsis" vol="2" page="e61">
<article-title>Diverse Signals Establish the Left-Right Body Axis</article-title>
</related-article><abstract><p>Members of the EGF-CFC family play essential roles in embryonic development and have been implicated in tumorigenesis. The TGF&#x003b2; signals Nodal and Vg1/GDF1, but not Activin, require EGF-CFC coreceptors to activate Activin receptors. We report that the TGF&#x003b2; signaling antagonist Lefty also acts through an EGF-CFC-dependent mechanism. Lefty inhibits Nodal and Vg1 signaling, but not Activin signaling. Lefty genetically interacts with EGF-CFC proteins and competes with Nodal for binding to these coreceptors. Chimeras between Activin and Nodal or Vg1 identify a 14 amino acid region that confers independence from EGF-CFC coreceptors and resistance to Lefty. These results indicate that coreceptors are targets for both TGF&#x003b2; agonists and antagonists and suggest that subtle sequence variations in TGF&#x003b2; signals result in greater ligand diversity.</p></abstract><abstract abstract-type="toc"><p>TGF&#x003b2; family members and their receptors are involved in setting up the left-right body axis early in development. This article clarifies the role of Lefty and elucidates the molecular basis for signaling diversity between the family members</p></abstract></article-meta></front><body><sec id="s1"><title>Introduction</title><p>The analysis of whole-genome sequences has revealed that most signaling systems consist of multiple ligands that converge on a relatively small set of receptors and pathway-specific transcription factors. In the case of human transforming growth factor-&#x003b2; (TGF&#x003b2;) signaling, 42 TGF&#x003b2;s converge on seven type I receptors, five type II receptors, and two classes of Smad signal transducers (reviewed in <xref rid="pbio-0020030-Shi1" ref-type="bibr">Shi and Massague 2003</xref>). This convergence has raised the question of how ligand diversity and signaling specificity among different signals can be achieved. If different TGF&#x003b2;s activate the same receptors, it is unclear how these ligands can vary in their function (diversity) or how a given signal can have a unique role (specificity). Biochemical studies have suggested that ligand diversity can be attained by differential stability and receptor affinity, leading to differences in signaling strength (reviewed in <xref rid="pbio-0020030-Piek1" ref-type="bibr">Piek et al. 1999</xref>; <xref rid="pbio-0020030-Shi1" ref-type="bibr">Shi and Massague 2003</xref>). An additional source of ligand variability stems from differential ligand movement through a field of cells, rendering related signals either short- or long-range (<xref rid="pbio-0020030-Chen2" ref-type="bibr">Chen and Schier 2001</xref>). Finally, specificity and diversity can also be determined by ligand-specific cofactors or inhibitors (<xref rid="pbio-0020030-Piek1" ref-type="bibr">Piek et al. 1999</xref>; <xref rid="pbio-0020030-Shi1" ref-type="bibr">Shi and Massague 2003</xref>). A prominent example involves epidermal growth factor&#x02013;Cripto/FRL-1/Cryptic (EGF-CFC) coreceptors and the TGF&#x003b2;s Activin, Nodal, and Vg1/GDF1 (growth and differentiation factor-1). In this case, differential dependence on a coreceptor leads to ligand diversity and signaling specificity (reviewed in <xref rid="pbio-0020030-Schier1" ref-type="bibr">Schier 2003</xref>).</p><p>Members of the Nodal, Activin, and Vg1/GDF1 subfamilies display similar activities and are potent mesendoderm inducers in vertebrates (reviewed in <xref rid="pbio-0020030-Schier2" ref-type="bibr">Schier and Shen 2000</xref>). Genetic and biochemical studies have shown that EGF-CFC proteins are essential for signaling by Nodal and Vg1/GDF1 (<xref rid="pbio-0020030-Gritsman1" ref-type="bibr">Gritsman et al. 1999</xref>; <xref rid="pbio-0020030-Reissmann1" ref-type="bibr">Reissmann et al. 2001</xref>; <xref rid="pbio-0020030-Yeo1" ref-type="bibr">Yeo and Whitman 2001</xref>; <xref rid="pbio-0020030-Bianco1" ref-type="bibr">Bianco et al. 2002</xref>; <xref rid="pbio-0020030-Sakuma1" ref-type="bibr">Sakuma et al. 2002</xref>; <xref rid="pbio-0020030-Yan2" ref-type="bibr">Yan et al. 2002</xref>; <xref rid="pbio-0020030-Cheng2" ref-type="bibr">Cheng et al. 2003</xref>). EGF-CFC proteins are extracellular glycosylphosphatidylinositol (GPI)-linked factors and include One-eyed pinhead (Oep) in zebrafish and mammalian Cripto and Cryptic (reviewed in <xref rid="pbio-0020030-Shen2" ref-type="bibr">Shen and Schier 2000</xref>; <xref rid="pbio-0020030-Minchiotti1" ref-type="bibr">Minchiotti et al. 2002</xref>; <xref rid="pbio-0020030-Schier1" ref-type="bibr">Schier 2003</xref>). Genetic studies in zebrafish and mouse have shown that EGF-CFC proteins and Nodal are required for mesoderm and endoderm induction (<xref rid="pbio-0020030-Conlon1" ref-type="bibr">Conlon et al. 1991</xref>, 1994; <xref rid="pbio-0020030-Zhou1" ref-type="bibr">Zhou et al. 1993</xref>; <xref rid="pbio-0020030-Ding1" ref-type="bibr">Ding et al. 1998</xref>; <xref rid="pbio-0020030-Feldman1" ref-type="bibr">Feldman et al. 1998</xref>; <xref rid="pbio-0020030-Gritsman1" ref-type="bibr">Gritsman et al. 1999</xref>). For example, zebrafish embryos lacking both the maternal and zygotic contribution of Oep (MZ<italic>oep</italic>) lack all endoderm and most mesoderm, similar to the double mutants for the zebrafish Nodal-related genes <italic>cyclops</italic> and <italic>squint</italic> (<italic>sqt</italic>) (<xref rid="pbio-0020030-Feldman1" ref-type="bibr">Feldman et al. 1998</xref>; <xref rid="pbio-0020030-Gritsman1" ref-type="bibr">Gritsman et al. 1999</xref>). Moreover, Nodal and Vg1/GDF1 are inactive in MZ<italic>oep</italic> mutants (<xref rid="pbio-0020030-Gritsman1" ref-type="bibr">Gritsman et al. 1999</xref>; <xref rid="pbio-0020030-Cheng2" ref-type="bibr">Cheng et al. 2003</xref>). During later stages of development, Oep, Cryptic, Nodal, and GDF1 are required for proper left&#x02013;right axis formation (<xref rid="pbio-0020030-Gaio1" ref-type="bibr">Gaio et al. 1999</xref>; <xref rid="pbio-0020030-Yan1" ref-type="bibr">Yan et al. 1999</xref>; <xref rid="pbio-0020030-Bamford1" ref-type="bibr">Bamford et al. 2000</xref>; <xref rid="pbio-0020030-Rankin1" ref-type="bibr">Rankin et al. 2000</xref>; <xref rid="pbio-0020030-Brennan1" ref-type="bibr">Brennan et al. 2002</xref>; <xref rid="pbio-0020030-Long1" ref-type="bibr">Long et al. 2003</xref>).</p><p>The EGF-CFC protein Cripto is highly overexpressed in human epithelial cancers, such as breast and colon carcinomas (reviewed in <xref rid="pbio-0020030-Salomon1" ref-type="bibr">Salomon et al. 2000</xref>), and has been implicated in tumorigenesis (<xref rid="pbio-0020030-Ciardiello1" ref-type="bibr">Ciardiello et al. 1991</xref>, 1994; <xref rid="pbio-0020030-Baldassarre1" ref-type="bibr">Baldassarre et al. 1996</xref>; <xref rid="pbio-0020030-De1" ref-type="bibr">De Luca et al. 2000</xref>; <xref rid="pbio-0020030-Salomon1" ref-type="bibr">Salomon et al. 2000</xref>; <xref rid="pbio-0020030-Adkins1" ref-type="bibr">Adkins et al. 2003</xref>). The mechanism by which Cripto mediates tumorigenesis is not well understood. Several possibilities include mediating Nodal/GDF1 signaling (<xref rid="pbio-0020030-Gritsman1" ref-type="bibr">Gritsman et al. 1999</xref>; <xref rid="pbio-0020030-Reissmann1" ref-type="bibr">Reissmann et al. 2001</xref>; <xref rid="pbio-0020030-Yeo1" ref-type="bibr">Yeo and Whitman 2001</xref>; <xref rid="pbio-0020030-Bianco1" ref-type="bibr">Bianco et al. 2002</xref>; <xref rid="pbio-0020030-Sakuma1" ref-type="bibr">Sakuma et al. 2002</xref>; <xref rid="pbio-0020030-Yan2" ref-type="bibr">Yan et al. 2002</xref>; <xref rid="pbio-0020030-Cheng2" ref-type="bibr">Cheng et al. 2003</xref>), antagonizing Activin signaling (<xref rid="pbio-0020030-Adkins1" ref-type="bibr">Adkins et al. 2003</xref>; <xref rid="pbio-0020030-Gray1" ref-type="bibr">Gray et al. 2003</xref>), or activating Akt and mitogen-activated protein kinase (MAPK) pathways independently of the TGF&#x003b2; signals and Activin receptors (<xref rid="pbio-0020030-Ebert1" ref-type="bibr">Ebert et al. </xref>1999; <xref rid="pbio-0020030-Bianco1" ref-type="bibr">Bianco et al. 2002</xref>, 2003). Whatever the molecular mechanism of Cripto activity, inhibition of Cripto by antisense or antibody blockade can inhibit tumor cell proliferation in vitro and in vivo (<xref rid="pbio-0020030-Ciardiello2" ref-type="bibr">Ciardiello et al. 1994</xref>; <xref rid="pbio-0020030-Baldassarre1" ref-type="bibr">Baldassarre et al. 1996</xref>; <xref rid="pbio-0020030-De1" ref-type="bibr">De Luca et al. 2000</xref>; <xref rid="pbio-0020030-Adkins1" ref-type="bibr">Adkins et al. 2003</xref>).</p><p>Biochemically, EGF-CFC proteins can act as coreceptors for Nodal and Vg1/GDF1 to bind and activate the type I Activin receptor Alk4 and the type II Activin receptor ActRIIB (<xref rid="pbio-0020030-Reissmann1" ref-type="bibr">Reissmann et al. 2001</xref>; <xref rid="pbio-0020030-Yeo1" ref-type="bibr">Yeo and Whitman 2001</xref>; <xref rid="pbio-0020030-Sakuma1" ref-type="bibr">Sakuma et al. 2002</xref>; <xref rid="pbio-0020030-Yan2" ref-type="bibr">Yan et al. 2002</xref>; <xref rid="pbio-0020030-Bianco1" ref-type="bibr">Bianco et al. 2002</xref>; <xref rid="pbio-0020030-Cheng2" ref-type="bibr">Cheng et al. 2003</xref>). In the absence of EGF-CFC proteins, these TGF&#x003b2;s cannot form a complex with Activin receptors. Strikingly, Activin utilizes the same receptors as Nodal and Vg1/GDF1, but does not require EGF-CFC coreceptors (<xref rid="pbio-0020030-Mathews1" ref-type="bibr">Mathews and Vale 1991</xref>; <xref rid="pbio-0020030-Attisano1" ref-type="bibr">Attisano et al. 1992</xref>, 1996; <xref rid="pbio-0020030-Hemmati-Brivanlou1" ref-type="bibr">Hemmati-Brivanlou and Melton 1992</xref>; <xref rid="pbio-0020030-Mathews2" ref-type="bibr">Mathews et al. 1992</xref>; <xref rid="pbio-0020030-ten1" ref-type="bibr">ten Dijke et al. 1994</xref>; <xref rid="pbio-0020030-Chang1" ref-type="bibr">Chang et al. 1997</xref>). For instance, Activin can signal in MZ<italic>oep</italic> mutants (<xref rid="pbio-0020030-Gritsman1" ref-type="bibr">Gritsman et al. 1999</xref>). This ligand diversity between Activin and Nodal or Vg1/GDF1 raises the question of which sequences confer coreceptor dependence or independence. Activin, Nodal, and Vg1/GDF1 are highly related and are thought to acquire very similar folds. Like other TGF&#x003b2; ligands, Activin has four major structural features: a &#x003b2;-stranded Finger 1, an &#x003b1;-helical Heel, a &#x003b2;-stranded Finger 2, and three conserved disulfide bonds that form a cysteine knot (<xref rid="pbio-0020030-Shi1" ref-type="bibr">Shi and Massague 2003</xref>; <xref rid="pbio-0020030-Thompson1" ref-type="bibr">Thompson et al. 2003</xref>). Sequence comparisons indicate that the highest divergence among Activin, Nodal, and Vg1/GDF1 is in the N-terminal segment of Finger 1, the central &#x003b1;-helix, and the loop of Finger 2 with approximately 10%, approximately 15%, and approximately 25% sequence identity, respectively. These regions are potential candidates to determine the specificity of receptor&#x02013;coreceptor&#x02013;ligand interactions.</p><p>In addition to coreceptors, antagonists represent another class of extracellular factors that control ligand access to receptors (reviewed in <xref rid="pbio-0020030-Piek1" ref-type="bibr">Piek et al. 1999</xref>; <xref rid="pbio-0020030-Freeman1" ref-type="bibr">Freeman 2000</xref>; <xref rid="pbio-0020030-De2" ref-type="bibr">De Robertis et al. 2001</xref>; <xref rid="pbio-0020030-Shi1" ref-type="bibr">Shi and Massague 2003</xref>). For example, the divergent TGF&#x003b2; class of Lefty proteins antagonizes Nodal signaling (reviewed in <xref rid="pbio-0020030-Hamada1" ref-type="bibr">Hamada et al. 2002</xref>; <xref rid="pbio-0020030-Schier1" ref-type="bibr">Schier 2003</xref>). Unlike other TGF&#x003b2;s, Lefty proteins may function as monomers due to the lack of a cysteine residue involved in dimerization (<xref rid="pbio-0020030-Meno1" ref-type="bibr">Meno et al. 1996</xref>; <xref rid="pbio-0020030-Thisse1" ref-type="bibr">Thisse and Thisse 1999</xref>; <xref rid="pbio-0020030-Sakuma1" ref-type="bibr">Sakuma et al. 2002</xref>). Lefty overexpression in zebrafish induces phenotypes identical to <italic>cyclops;sqt</italic> double mutants and MZ<italic>oep</italic> mutants (<xref rid="pbio-0020030-Bisgrove1" ref-type="bibr">Bisgrove et al. 1999</xref>; <xref rid="pbio-0020030-Meno4" ref-type="bibr">Meno et al. 1999</xref>; <xref rid="pbio-0020030-Thisse1" ref-type="bibr">Thisse and Thisse 1999</xref>). Furthermore, the loss of Lefty activity leads to enhanced Nodal signaling during mesoderm induction and left&#x02013;right axis determination (<xref rid="pbio-0020030-Meno4" ref-type="bibr">Meno et al. 1999</xref>, 2001; <xref rid="pbio-0020030-Agathon1" ref-type="bibr">Agathon et al. 2001</xref>; <xref rid="pbio-0020030-Branford1" ref-type="bibr">Branford and Yost 2002</xref>; <xref rid="pbio-0020030-Chen3" ref-type="bibr">Chen and Schier 2002</xref>; <xref rid="pbio-0020030-Feldman2" ref-type="bibr">Feldman et al. 2002</xref>). Although it has not been determined whether Lefty directly blocks Vg1/GDF1 signaling (<xref rid="pbio-0020030-Branford2" ref-type="bibr">Branford et al. 2000</xref>), it has been proposed that Lefty inhibits signaling by Activin. Misexpression of Activin or ActRIIB can overcome the inhibitory effects of Lefty (<xref rid="pbio-0020030-Meno4" ref-type="bibr">Meno et al. 1999</xref>; <xref rid="pbio-0020030-Thisse1" ref-type="bibr">Thisse and Thisse 1999</xref>; <xref rid="pbio-0020030-Cheng1" ref-type="bibr">Cheng et al. 2000</xref>; <xref rid="pbio-0020030-Tanegashima1" ref-type="bibr">Tanegashima et al. 2000</xref>; <xref rid="pbio-0020030-Sakuma1" ref-type="bibr">Sakuma et al. 2002</xref>). Hence, some members of the Lefty family have been called Antivins for their anti-Activin properties (<xref rid="pbio-0020030-Thisse1" ref-type="bibr">Thisse and Thisse 1999</xref>; <xref rid="pbio-0020030-Cheng1" ref-type="bibr">Cheng et al. 2000</xref>; <xref rid="pbio-0020030-Ishimaru1" ref-type="bibr">Ishimaru et al. 2000</xref>; <xref rid="pbio-0020030-Tanegashima1" ref-type="bibr">Tanegashima et al. 2000</xref>). However, it has been elusive how Lefty functions at the molecular level.</p><p>Here we present genetic and biochemical studies in zebrafish and <italic>Xenopus</italic> that indicate that Lefty is an in vivo antagonist of EGF-CFC coreceptors. We find that Lefty can antagonize signaling by the coreceptor-dependent ligands Nodal and Vg1/GDF1, but not Activin. Lefty genetically interacts with Cripto and Oep and competes with Nodal for binding to Cripto, representing a novel mechanism for antagonizing TGF&#x003b2; signaling. We identify a short region in Finger 2 of Activin, Nodal, and Vg1 that determines EGF-CFC coreceptor-dependent or coreceptor-independent signaling and governs susceptibility to Lefty. These results indicate that subtle sequence variations in TGF&#x003b2; ligands can dramatically expand signaling diversity by determining interactions with coreceptors and their antagonists.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Lefty Antagonizes Nodal and Vg1 Signaling, but Not Activin Signaling</title><p>TGF&#x003b2; ligands that activate Activin receptors can be categorized into two classes. The Activin class activates Activin receptors in an EGF-CFC coreceptor-independent manner, whereas the Nodal and Vg1/GDF1 classes require EGF-CFC proteins for receptor activation (<xref rid="pbio-0020030-Gritsman1" ref-type="bibr">Gritsman et al. 1999</xref>; <xref rid="pbio-0020030-Cheng2" ref-type="bibr">Cheng et al. 2003</xref>). To determine whether these classes are also differentially susceptible to inhibition by the TGF&#x003b2; antagonist Lefty, we coexpressed zebrafish Lefty1 with <italic>Xenopus</italic> Activin&#x003b2;B, <italic>Xenopus</italic> Activin&#x003b2;A, Sqt (a zebrafish Nodal-related protein), or zebrafish Vg1 (a chimeric molecule containing the <italic>Xenopus</italic> Activin&#x003b2;B prodomain fused to the mature domain of zebrafish Vg1) in zebrafish embryos (<xref rid="pbio-0020030-Smith1" ref-type="bibr">Smith et al. 1990</xref>; <xref rid="pbio-0020030-Thomsen1" ref-type="bibr">Thomsen et al. 1990</xref>; <xref rid="pbio-0020030-van1" ref-type="bibr">van den Eijnden-Van Raaij et al. 1990</xref>; <xref rid="pbio-0020030-Helde1" ref-type="bibr">Helde and Grunwald 1993</xref>; Erter et al. 1998; <xref rid="pbio-0020030-Feldman1" ref-type="bibr">Feldman et al. 1998</xref>; <xref rid="pbio-0020030-Thisse1" ref-type="bibr">Thisse and Thisse 1999</xref>). As a readout for active signaling, we analyzed the ectopic induction of the Nodal downstream gene <italic>goosecoid</italic> (<italic>gsc</italic>). Activin&#x003b2;B, Activin&#x003b2;A, Sqt, and Vg1-induced ectopic <italic>gsc</italic> expression in wild-type embryos (<xref ref-type="fig" rid="pbio-0020030-g001">Figure 1</xref>D, <xref ref-type="fig" rid="pbio-0020030-g001">1</xref>G, <xref ref-type="fig" rid="pbio-0020030-g001">1</xref>J, and <xref ref-type="fig" rid="pbio-0020030-g001">1</xref>M; <xref rid="pbio-0020030-Gritsman1" ref-type="bibr">Gritsman et al. 1999</xref>; <xref rid="pbio-0020030-Cheng2" ref-type="bibr">Cheng et al. 2003</xref>). Coexpression of Lefty1 efficiently inhibited <italic>gsc</italic> induction by Sqt (<xref ref-type="fig" rid="pbio-0020030-g001">Figure 1</xref>K and <xref ref-type="fig" rid="pbio-0020030-g001">1</xref>L; <xref rid="pbio-0020030-Bisgrove1" ref-type="bibr">Bisgrove et al. 1999</xref>; <xref rid="pbio-0020030-Meno4" ref-type="bibr">Meno et al. 1999</xref>; <xref rid="pbio-0020030-Thisse3" ref-type="bibr">Thisse et al. 2000</xref>) and Vg1 (<xref ref-type="fig" rid="pbio-0020030-g001">Figure 1</xref>N and <xref ref-type="fig" rid="pbio-0020030-g001">1</xref>O), but not Activin&#x003b2;B or Activin&#x003b2;A (<xref ref-type="fig" rid="pbio-0020030-g001">Figure 1</xref>E, <xref ref-type="fig" rid="pbio-0020030-g001">1</xref>F, <xref ref-type="fig" rid="pbio-0020030-g001">1</xref>H, and <xref ref-type="fig" rid="pbio-0020030-g001">1</xref>I). To examine whether Lefty1 can antagonize the induction of a gene that responds to very low levels of Activin signaling, we titrated Activin&#x003b2;B levels so that <italic>no tail</italic> (<italic>ntl</italic>; also known as <italic>brachyury/T</italic>) expression was only weakly induced (see arrowhead in <xref ref-type="fig" rid="pbio-0020030-g001">Figure 1</xref>A). The coexpression of Lefty1 did not inhibit <italic>ntl</italic> induction by Activin&#x003b2;B (<xref ref-type="fig" rid="pbio-0020030-g001">Figure 1</xref>B and <xref ref-type="fig" rid="pbio-0020030-g001">1</xref>C), but inhibited the dorsal margin expression of <italic>ntl</italic> that is dependent on endogenous Nodal signaling (see asterisks in <xref ref-type="fig" rid="pbio-0020030-g001">Figure 1</xref>B and <xref ref-type="fig" rid="pbio-0020030-g001">1</xref>C; <xref rid="pbio-0020030-Feldman1" ref-type="bibr">Feldman et al. 1998</xref>). In a more quantitative assay, we overexpressed Lefty1, Activin&#x003b2;B, Sqt, and Vg1 in zebrafish embryos in the presence of the luciferase reporter A3-luc, which contains FoxH1/P-Smad2 response elements (<xref rid="pbio-0020030-Chen1" ref-type="bibr">Chen et al. 1996</xref>). Consistent with the <italic>gsc</italic> and <italic>ntl</italic> induction assays, Sqt and Vg1 signaling, but not Activin&#x003b2;B signaling, is inhibited by Lefty1 (<xref ref-type="fig" rid="pbio-0020030-g001">Figure 1</xref>P). These results indicate that Lefty1 efficiently antagonizes Nodal and Vg1/GDF1 signaling, but not Activin signaling.</p><fig id="pbio-0020030-g001" position="float"><label>Figure 1</label><caption><title>Lefty Antagonizes Nodal and Vg1 Signaling, but Not Activin Signaling, in Zebrafish</title><p>
<italic>ntl</italic> mRNA expression (A&#x02013;C) and <italic>gsc</italic> mRNA expression (D&#x02013;O) in wild-type zebrafish embryos at shield stage, animal pole view. Embryos were injected with low levels (1 pg) of <italic>activin &#x003b2;B</italic> mRNA (A&#x02013;C), high levels (10 pg) of <italic>activin &#x003b2;B</italic> mRNA (D&#x02013;F), 200 pg of <italic>activin &#x003b2;A</italic> mRNA (G&#x02013;I), 75 pg of <italic>sqt</italic> mRNA (J&#x02013;L), or 200 pg of <italic>Vg1</italic> (M&#x02013;O). Embryos were further double-injected with either 500 pg of <italic>LacZ</italic> mRNA (A, D, G, J, and M), 100 pg of <italic>lefty1</italic> and 400 pg of <italic>LacZ</italic> mRNAs (B, E, H, K, and N), or 500 pg of <italic>lefty1</italic> mRNA (C, F, I, L, and O). Ectopic <italic>ntl</italic> expression (arrowheads) in <italic>activin &#x003b2;B</italic> mRNA-injected embryos was not inhibited by Lefty1 (B and C) when compared with <italic>LacZ</italic> mRNA-coinjected controls (A). Note the dorsal expression of <italic>ntl</italic> (asterisks)&#x02014;that is, dependent on endogenous Nodal signaling&#x02014;is inhibited by Lefty1 in these embryos (B and C). Ectopic <italic>gsc</italic> expression in <italic>activin &#x003b2;B</italic> and <italic>activin &#x003b2;A</italic> mRNA-injected embryos was not inhibited by Lefty1 (E and F and H and I, respectively). In contrast, ectopic <italic>gsc</italic> expression in <italic>sqt</italic> and <italic>Vg1</italic> mRNA-injected embryos was inhibited by both levels of Lefty expression (K and L and N and O, respectively). Wild-type embryos (P) were injected with 10 pg (low) and 20 pg (high) of <italic>activin &#x003b2;B</italic>/HA, 75 pg of <italic>sqt</italic>, or 200 pg of <italic>Vg1</italic> mRNA. Embryos were further double-injected with 500 pg of <italic>LacZ</italic> mRNA, 100 pg of <italic>lefty1</italic>, and 400 pg of <italic>LacZ</italic> mRNAs, or 500 pg of <italic>lefty1</italic> mRNA. Smad2 pathway activation was measured by an Activin response element luciferase reporter, A3-luc. Values are folds over wild-type control injected with 500 pg of <italic>LacZ</italic> mRNA and A3-luc reporter. An asterisk indicates a significant difference from the level of activation with ligand and <italic>LacZ</italic> expression alone (Student's <italic>t</italic>-test, <italic>p</italic> &#x0003c; 0.05).</p></caption><graphic xlink:href="pbio.0020030.g001"/></fig></sec><sec id="s2b"><title>EGF-CFC Proteins Genetically Interact with Lefty</title><p>The molecular mechanism of Lefty action has been unresolved. Lefty seems to act upstream of the Activin receptors, as Lefty cannot block signaling from ligand-independent constitutively activated receptors (<xref rid="pbio-0020030-Thisse1" ref-type="bibr">Thisse and Thisse 1999</xref>). Our finding that Lefty blocks Nodal and Vg1 signaling, but not Activin signaling, suggests that Lefty blocks extracellular components specific to the Nodal and Vg1 pathways. The only such factors identified to date are the EGF-CFC coreceptors. We therefore examined whether the EGF-CFC genes zebrafish <italic>oep</italic> and mouse <italic>Cripto</italic> genetically interact with Lefty1. Overexpression of Lefty1 in wild-type zebrafish resulted in embryos lacking head and trunk mesendoderm due to inhibition of endogenous Nodal signaling (<xref ref-type="fig" rid="pbio-0020030-g002">Figure 2</xref>A1 and <xref ref-type="fig" rid="pbio-0020030-g002">2</xref>A&#x02032;; <xref rid="pbio-0020030-Bisgrove1" ref-type="bibr">Bisgrove et al. 1999</xref>; <xref rid="pbio-0020030-Meno4" ref-type="bibr">Meno et al. 1999</xref>; <xref rid="pbio-0020030-Thisse1" ref-type="bibr">Thisse and Thisse 1999</xref>). Coexpression of Cripto or Oep partially suppressed Lefty-induced defects (<xref ref-type="fig" rid="pbio-0020030-g002">Figure 2</xref>B1&#x02013;<xref ref-type="fig" rid="pbio-0020030-g002">2</xref>B3; data not shown), restoring trunk and head mesoderm, including the notochord, and resulting in the separation of the eye field into two eyes. These results indicate an antagonistic relationship between EGF-CFC coreceptors and Leftys.</p><fig id="pbio-0020030-g002" position="float"><label>Figure 2</label><caption><title>EGF-CFC Coreceptors Genetically Interact with Lefty</title><p>Live wild-type zebrafish embryos at 30 h postfertilization (hpf).</p><p>(A1, B1, and C1) Ventral views of the head.</p><p>(A1&#x02032;, B2, B3, and C1&#x02032;) Lateral views, with anterior to the left, dorsal up.</p><p>(A1, A1&#x02032;, B1, B2, and B3) Wild-type embryos were injected with 20 pg of <italic>lefty1</italic> mRNA. Embryos were further double-injected with either 200 pg of <italic>LacZ</italic> mRNA (A1 and A1&#x02032;) or 200 pg of <italic>Cripto</italic> mRNA (B1, B2, and B3).</p><p>(C1 and C1&#x02032;) Wild-type embryos injected with 200 pg of <italic>Cripto</italic> mRNA and 20 pg of <italic>LacZ</italic> mRNA.</p><p>Misexpression of Lefty1 results in cyclopia and other head and trunk mesoderm defects ([A1 and A1&#x02032;] 32 of 32 embryos had the phenotype shown; arrow shows cyclopia). Coexpression of Cripto with Lefty in embryos leads to rescue of two eyes ([B1] four of 50; arrows show two eyes), notochord ([B2] 20 of 50; inset shows trunk somites and notochord, red bar delineates notochord), and trunk somites ([B3] 50 of 50). Embryos injected with <italic>Cripto</italic> mRNA only show normal wild-type phenotype ([C1 and C1&#x02032;] 30 of 30; arrow in [C1] shows two normal eyes, and inset in [C1&#x02032;] shows normal notochord and trunk somites, red bar delineates notochord).</p></caption><graphic xlink:href="pbio.0020030.g002"/></fig></sec><sec id="s2c"><title>Lefty Binds to Cripto, but Not to ActRIIB or Alk4</title><p>Because Lefty and EGF-CFC proteins interact genetically, we examined whether Lefty interacts biochemically with Cripto and/or ActRIIB/Alk4 receptor complexes. We expressed and immunoprecipitated epitope-tagged ligands (zebrafish Lefty1/HA [hemagglutinin], zebrafish Lefty1/Glu, or zebrafish Sqt/HA), receptors (mouse ActRIIB[KR]/Myc and human Alk4[KR]/Flag), and a coreceptor (mouse Cripto/Flag) in <italic>Xenopus</italic> embryos (<xref rid="pbio-0020030-Yeo1" ref-type="bibr">Yeo and Whitman 2001</xref>; <xref rid="pbio-0020030-Cheng2" ref-type="bibr">Cheng et al. 2003</xref>). Similar to other Nodal-related proteins (<xref rid="pbio-0020030-Reissmann1" ref-type="bibr">Reissmann et al. 2001</xref>; <xref rid="pbio-0020030-Yeo1" ref-type="bibr">Yeo and Whitman 2001</xref>; <xref rid="pbio-0020030-Bianco1" ref-type="bibr">Bianco et al. 2002</xref>; <xref rid="pbio-0020030-Sakuma1" ref-type="bibr">Sakuma et al. 2002</xref>; <xref rid="pbio-0020030-Yan2" ref-type="bibr">Yan et al. 2002</xref>), Sqt formed a complex with the type II receptor ActRIIB, type I receptor Alk4, and Cripto (<xref ref-type="fig" rid="pbio-0020030-g003">Figure 3</xref>A). In contrast, Lefty1 coimmunoprecipitated Cripto, but not ActRIIB or Alk4 (<xref ref-type="fig" rid="pbio-0020030-g003">Figure 3</xref>A). Since Cripto is bound to Alk4 even in the absence of ligand (<xref rid="pbio-0020030-Reissmann1" ref-type="bibr">Reissmann et al. 2001</xref>; <xref rid="pbio-0020030-Yeo1" ref-type="bibr">Yeo and Whitman 2001</xref>; <xref rid="pbio-0020030-Bianco1" ref-type="bibr">Bianco et al. 2002</xref>; <xref rid="pbio-0020030-Yan2" ref-type="bibr">Yan et al. 2002</xref>), Lefty seemed to disrupt the Cripto&#x02013;Alk4 interaction. In reverse experiments, Cripto efficiently coimmunoprecipitated Lefty1 (<xref ref-type="fig" rid="pbio-0020030-g003">Figure 3</xref>B). Since Sqt and Lefty1 can both bind to Cripto (<xref ref-type="fig" rid="pbio-0020030-g003">Figure 3</xref>C; <xref rid="pbio-0020030-Reissmann1" ref-type="bibr">Reissmann et al. 2001</xref>; <xref rid="pbio-0020030-Yeo1" ref-type="bibr">Yeo and Whitman 2001</xref>; <xref rid="pbio-0020030-Bianco1" ref-type="bibr">Bianco et al. 2002</xref>; <xref rid="pbio-0020030-Sakuma1" ref-type="bibr">Sakuma et al. 2002</xref>; <xref rid="pbio-0020030-Yan2" ref-type="bibr">Yan et al. 2002</xref>), these two ligands might compete for binding to Cripto. Indeed, the coexpression of Lefty1 led to decreased interactions between Cripto and Sqt (<xref ref-type="fig" rid="pbio-0020030-g003">Figure 3</xref>C). To determine whether Cripto can directly interact with Lefty, we immunoprecipitated purified mouse Lefty1 protein (mLefty1) in the presence of either purified mouse Cripto protein or a control cysteine-rich protein, mouse vascular endothelial growth factor-D (VEGF-D). mLefty1 protein directly interacted with Cripto, but not with VEGF-D. Together, these results suggest that Lefty inhibits Nodal signaling by associating with Cripto and blocking it from interacting with Nodal.</p><fig id="pbio-0020030-g003" position="float"><label>Figure 3</label><caption><title>Lefty Binds to Cripto, but Not to the Activin Receptors ActRIIB and Alk4</title><p>(A and B) Lefty1 interacts with Cripto. RNAs (1 ng each) encoding ActRIIB(KR)/Myc, Alk4(KR)/Flag, Cripto/Flag, Lefty1/HA, or Sqt/HA were injected into <italic>Xenopus</italic> embryos. After chemical cross-linking, lysates were immunoprecipitated for either Lefty1/HA or Sqt/HA (A) with anti-HA antibody, or ActRIIB(KR)/Myc, Alk4(KR)/HA, Cripto/Flag (B) with, respectively, anti-Myc, anti-HA, or anti-Flag antibodies. Note that Lefty1 specifically interacts with Cripto (A and B), and these Lefty/Cripto complexes do not contain Alk4 (A). Moreover, processed Lefty1 binds much more efficiently to Cripto than full-length Lefty1 precursor (B). In contrast, Sqt can bind to ActRIIB, Alk4, and Cripto (A). The 55 kDa protein marker in (B) is estimated based on molecular weight markers.</p><p>(C) Lefty1 competes with Nodal for binding to Cripto. RNAs encoding Sqt/HA (1 ng), Cripto/Flag (100 pg), or Lefty1 (2 ng) were injected and anti-Flag antibody was used to immunopreciptate Cripto/Flag.</p><p>(D) mLefty1 binds directly to Cripto. Purified mouse Lefty1 protein (mLefty1; 10 &#x003bc;g/ml) was mixed with either soluble purified Cripto/His protein (5 &#x003bc;g/ml) or purified control VEGF-D/His protein (5 &#x003bc;g/ml). After chemical cross-linking, mLefty1 was immunoprecipitated with anti-mLefty1 antibody. mLefty1 associates with Cripto, but not with control VEGF-D.</p><p>Proteins in the coimmunoprecipitates and total extracts were probed in Western blot analysis with the indicated antibodies: ActRIIB(KR)/Myc (kinase-defective receptor, approximately 120 kDa; anti-Myc), Alk4(KR)/Flag (kinase-defective receptor, approximately 70 kDa; anti-Flag), Cripto/Flag (approximately 30 kDa; anti-Flag), Lefty1/HA (mature ligand, approximately 36&#x02013;40 kDa; anti-HA; <xref rid="pbio-0020030-Sakuma1" ref-type="bibr">Sakuma et al. 2002</xref>), Sqt/HA (unprocessed precursor, approximately 55 kDa; mature ligand, approximately 22 kDa; anti-HA), Lefty1/Glu (unprocessed precursor, approximately 55 kDa; mature ligand, approximately 38 kDa; anti-Glu; <xref rid="pbio-0020030-Sakuma1" ref-type="bibr">Sakuma et al. 2002</xref>), mLefty1 (mature ligand, approximately 36 kDa, anti-mLefty1; <xref rid="pbio-0020030-Sakuma1" ref-type="bibr">Sakuma et al. 2002</xref>), Cripto/His (soluble form, approximately 22&#x02013;25 kDa; anti-His), and VEGF-D/His (mature ligand, approximately 15&#x02013;20 kDa; anti-His).</p></caption><graphic xlink:href="pbio.0020030.g003"/></fig></sec><sec id="s2d"><title>Activin Loop-&#x003b2;8 Region Confers EGF-CFC Coreceptor Independence to Sqt</title><p>The finding that TGF&#x003b2; ligands that activate Activin receptors can be grouped into a EGF-CFC coreceptor-dependent class that is susceptible to inhibition by Lefty (Nodal and Vg1) and a class that is independent of EGF-CFC proteins and resistant to Lefty (Activin) prompted us to examine which sequences underlie this ligand diversity. We therefore generated chimeras between Activins (EGF-CFC-independent) and Sqt or Vg1 (EGF-CFC-dependent) (Figures <xref ref-type="fig" rid="pbio-0020030-g004">4</xref> and <xref ref-type="fig" rid="pbio-0020030-g005">5</xref>). As a readout for active signaling, we injected mRNAs encoding these chimeric ligands into wild-type and MZo<italic>ep</italic> zebrafish embryos and analyzed the ectopic induction of the downstream genes <italic>ntl</italic> and <italic>gsc</italic>. Sqt, Vg1, and Activins induced these genes in wild-type embryos, allowing us to determine which chimeric ligands were active. Activins, but not Sqt or Vg1, were active in MZ<italic>oep</italic> mutants, allowing us to test which sequences conferred EGF-CFC coreceptor dependence or independence.</p><fig id="pbio-0020030-g004" position="float"><label>Figure 4</label><caption><title>Chimera Analysis to Identify TGF&#x003b2; Sequence Determinants Conferring EGF-CFC Coreceptor Dependence or Independence</title><p>Schematic depiction of chimeras of mature ligand domains, Finger 1 (F1), Heel (H), and Finger 2 (F2), between <italic>Xenopus</italic> Activin&#x003b2;B and zebrafish Sqt. HA indicates an hemagglutinin epitope tag. Schematic is not drawn to scale. The letters in these three-lettered (XXX) chimeras represent the Finger 1, Heel, and Finger 2, respectively. <italic>S</italic> denotes Squint; <italic>A</italic> denotes Activin&#x003b2;B. Synthetic mRNAs (200 pg) encoding chimeras were injected into wild-type and MZ<italic>oep</italic> embryos. <italic>gsc</italic> and <italic>ntl</italic> mRNA expression is shown at shield stage; animal pole views are dorsal to the right. <italic>gsc</italic> is expressed in the dorsal organizer (shield) in wild-type embryos, but is absent in MZ<italic>oep</italic> mutants. <italic>ntl</italic> is expressed around the entire margin in wild-type embryos, but the dorsal margin expression is lost in MZ<italic>oep</italic> mutants. The presence of the Activin&#x003b2;B prodomain and epitope tag does not alter the specificity or functionality of wild-type Activin&#x003b2;B (AAA) or Sqt (SSS). AAA can induce ectopic <italic>gsc</italic> and <italic>ntl</italic> expression in both wild-type and MZ<italic>oep</italic> embryos. In contrast, SSS can induce ectopic <italic>gsc</italic> and <italic>ntl</italic> expression in only wild-type embryos. Similar to Activin&#x003b2;B, chimeras SSA, SAS, ASA, and SAA can induce ectopic <italic>gsc</italic> and <italic>ntl</italic> expression in both wild-type and MZ<italic>oep</italic> embryos. Chimeras ASS and AAS are inactive in both wild-type and MZ<italic>oep</italic> embryos. Western blot analysis indicated that all chimeric constructs produce stable ligands (data not shown).</p></caption><graphic xlink:href="pbio.0020030.g004"/></fig><fig id="pbio-0020030-g005" position="float"><label>Figure 5</label><caption><title>Sequence Determinants Conferring Independence from EGF-CFC Coreceptors</title><p>(A) Sequence alignment of Finger 2 region of EGF-CFC-dependent and EGF-CFC-independent TGF&#x003b2; ligands. Location of secondary structure elements, &#x003b2;-sheets (&#x003b2;6&#x02013;&#x003b2;9) and loop, are shown (<xref rid="pbio-0020030-Kirsch1" ref-type="bibr">Kirsch et al. 2000</xref>). Residue numbering is from mouse Activin&#x003b2;A.</p><p>(B&#x02013;E) Synthetic mRNAs (200 pg) encoding chimeras of Finger 2 subregions between <italic>Xenopus</italic> Activin&#x003b2;B or Activin&#x003b2;A and zebrafish Sqt or Vg1 were injected into wild-type and MZ<italic>oep</italic> embryos. Schematic is not drawn to scale. <italic>gsc</italic> and <italic>ntl</italic> mRNA expression is at shield stage; animal pole views are dorsal to the right.</p><p>(B) Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8</sup>
<sup>&#x003b2;</sup>
<sup>9]</sup> and Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> can induce <italic>gsc</italic> and <italic>ntl</italic> expression in both wild-type and MZ<italic>oep</italic> embryos.</p><p>(C) Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> can weakly expand <italic>ntl</italic> expression in MZ<italic>oep</italic> mutants. <italic>ntl</italic> mRNA expression in MZ<italic>oep</italic> mutants is at shield stage; lateral view.</p><p>(D) Other TGF&#x003b2;s conform to loop-&#x003b2;8 EGF-CFC-independent determinant. Note that <italic>Xenopus</italic> Activin&#x003b2;A can induce ectopic <italic>gsc</italic> in both wild-type and MZ<italic>oep</italic> embryos. In contrast, Vg1 can only induce <italic>gsc</italic> in wild-type embryos. Similar to Activins, chimeric Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>A[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> and Vg1<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> can induce ectopic <italic>gsc</italic> in both wild-type and MZ<italic>oep</italic> embryos.</p><p>(E) Wild-type and MZoep embryos were injected with 5 pg of <italic>activin &#x003b2;B</italic>, 100 pg of <italic>sqt</italic>, 100 pg of <italic>Vg1</italic>, 125 pg of <italic>Sqt<sup>Act&#x003b2;B[loop&#x003b2;8]</sup></italic>, 250 pg of <italic>Sqt<sup>Act&#x003b2;A[loop&#x003b2;8]</sup></italic>, or 100 pg of <italic>Vg1<sup>Act&#x003b2;B[loop&#x003b2;8]</sup></italic> mRNA. Smad2 pathway activation was measured by an Activin response element luciferase reporter, A3-luc. Luciferase units are relative to wild-type or MZ<italic>oep</italic> control injected with the A3-luc reporter alone.</p><p>(F) Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> can bind to ActRIIB and Alk4 in the absence of EGF-CFC coreceptors. RNAs (1 ng each) encoding ActRIIB(KR)/Myc, Alk4(KR)/Flag, Cripto/Flag, Activin&#x003b2;B/HA, Sqt/HA, or Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup>/HA were injected into <italic>Xenopus</italic> embryos. Proteins in the coimmunoprecipitates and total extracts were probed in Western blot analysis with the indicated antibodies: ActRIIB(KR)/Myc (approximately 120 kDa; anti-Myc), Alk4(KR)/Flag (approximately 70 kDa; anti-Flag), Cripto/Flag (approximately 30 kDa; anti-Flag), Activin&#x003b2;B/HA (mature ligand, approximately 16 kDa; anti-HA), Sqt/HA (mature ligand, approximately 22 kDa; anti-HA), and Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup>/HA (mature ligand, approximately 22 kDa; anti-HA).</p></caption><graphic xlink:href="pbio.0020030.g005"/></fig><p>Initially, swaps of the Finger 1, Heel, or Finger 2 domains of Sqt and Activin&#x003b2;B were generated. As shown in <xref ref-type="fig" rid="pbio-0020030-g004">Figure 4</xref>, the Finger 2 region of Activin&#x003b2;B contains sequence determinants that conferred EGF-CFC-independent activity on chimeric ligands. Chimeric SSA, ASA, and SAA that contain the Finger 2 region of Activin&#x003b2;B were active in both wild-type and MZ<italic>oep</italic> embryos (<xref ref-type="fig" rid="pbio-0020030-g004">Figure 4</xref>). To further delineate this region, we generated additional chimeras (<xref ref-type="fig" rid="pbio-0020030-g005">Figure 5</xref>B). Short stretches of full-length Sqt were replaced by the corresponding region of Activin&#x003b2;B, including the &#x003b2;6&#x003b2;7, loop, &#x003b2;8, or &#x003b2;9 subregions (<xref ref-type="fig" rid="pbio-0020030-g005">Figure 5</xref>A and <xref ref-type="fig" rid="pbio-0020030-g005">5</xref>B; data not shown). Analysis of these chimeras revealed that the 14 amino acids encoding the loop and &#x003b2;8 region of Activin&#x003b2;B (Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup>; the bracketed region in superscript denotes substituted domains) were sufficient to confer EGF-CFC independence. Further dissection of this region into loop alone (Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop]</sup>) or &#x003b2;8 alone (Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup>) yielded no or much weaker activity in MZ<italic>oep</italic> mutants as compared with wild-type embryos (<xref ref-type="fig" rid="pbio-0020030-g005">Figure 5</xref>B and <xref ref-type="fig" rid="pbio-0020030-g005">5</xref>C). These results suggest that a 14 amino acid region in Activin is sufficient to confer EGF-CFC independence when placed into Sqt.</p></sec><sec id="s2e"><title>Activin Loop-&#x003b2;8 Region Confers EGF-CFC Coreceptor Independence to Vg1</title><p>To determine whether the loop-&#x003b2;8 region has a wider role in conferring coreceptor independence, we generated additional chimeras using Activin&#x003b2;A (another EGF-CFC-independent ligand) and Vg1. Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>A[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> (full-length Sqt with an Activin&#x003b2;A loop-&#x003b2;8 region) and Vg1<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> (Vg1 with an Activin&#x003b2;B loop-&#x003b2;8 region) both induced <italic>gsc</italic> expression in MZ<italic>oep</italic> mutants with similar efficiencies as in wild-type embryos (<xref ref-type="fig" rid="pbio-0020030-g005">Figure 5</xref>D). These results were also corroborated using the A3-luc reporter assay (<xref ref-type="fig" rid="pbio-0020030-g005">Figure 5</xref>E) and suggest that the loop-&#x003b2;8 region has a general role in conferring EGF-CFC coreceptor independence.</p></sec><sec id="s2f"><title>Activin Loop-&#x003b2;8 Region Confers Binding to Activin Receptors in the Absence of EGF-CFC Coreceptors</title><p>Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> can signal in an EGF-CFC-independent manner in vivo, suggesting that this chimeric protein might bind to ActRIIB and Alk4 receptors in the absence of EGF-CFC coreceptors. To test this idea, we coexpressed and immunoprecipitated epitope-tagged ligands (Activin&#x003b2;B/HA, Sqt/HA, Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup>/HA), receptors (ActRIIB[KR]/Myc and Alk4[KR]/Flag), and a coreceptor (Cripto/Flag) in <italic>Xenopus</italic> embryos (<xref rid="pbio-0020030-Yeo1" ref-type="bibr">Yeo and Whitman 2001</xref>; <xref rid="pbio-0020030-Cheng2" ref-type="bibr">Cheng et al. 2003</xref>). We found that Sqt binding to the ActRIIB and Alk4 receptor complex required Cripto (<xref ref-type="fig" rid="pbio-0020030-g005">Figure 5</xref>F). In contrast, Activin&#x003b2;B and Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> can bind to Activin receptors in the absence of Cripto. Moreover, Cripto did not significantly increase Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> ligand&#x02013;receptor complex formation. These results indicate that the loop-&#x003b2;8 region is a determinant of TGF&#x003b2; ligand binding to Activin receptors independent of EGF-CFC coreceptors.</p></sec><sec id="s2g"><title>Multiple Residues in the Loop-&#x003b2;8 Region Contribute to Coreceptor Independence</title><p>An alignment of the loop-&#x003b2;8 region of EGF-CFC-dependent and EGF-CFC-independent TGF&#x003b2;s (<xref ref-type="fig" rid="pbio-0020030-g005">Figure 5</xref>A) reveals the presence of several residues unique to Activins. These include (i) a Lys102&#x02013;X&#x02013;Asp104 motif (numbering from Activin&#x003b2;A) that forms a significant binding interface with the type II receptor ActRII (<xref rid="pbio-0020030-Wuytens1" ref-type="bibr">Wuytens et al. 1999</xref>; <xref rid="pbio-0020030-Greenwald1" ref-type="bibr">Greenwald et al. 2003</xref>; <xref rid="pbio-0020030-Thompson1" ref-type="bibr">Thompson et al. 2003</xref>); (ii) Gln/Pro106 and Asn107, which contribute to the dimerization interface responsible for conformational arrangement (<xref rid="pbio-0020030-Thompson1" ref-type="bibr">Thompson et al. 2003</xref>); and (iii) an Asn insertion at position 99. We therefore mutated the corresponding residues in Sqt, individually or in combination, to the Activin&#x003b2;B sequence and tested them in the <italic>gsc</italic>/<italic>ntl</italic> induction assay (<xref ref-type="fig" rid="pbio-0020030-g006">Figure 6</xref>). All constructs were active in wild-type embryos. The Sqt3 and Sqt5 constructs containing the Lys102&#x02013;X&#x02013;Asp104 motif and Asn99 insertion showed weak expansion of <italic>ntl</italic> expression animally and dorsally in MZ<italic>oep</italic> mutants. The incorporation of Pro106&#x02013;Asn107 (Sqt2, Sqt4, and Sqt5) in Sqt did not enhance activity in MZ<italic>oep</italic> mutants. These results suggest that multiple residues contribute to coreceptor independence, with the type II receptor-binding interface being an essential determinant.</p><fig id="pbio-0020030-g006" position="float"><label>Figure 6</label><caption><title>Conserved Residues in Activin Loop-&#x003b2;8 Region Confer Independence from EGF-CFC Coreceptors</title><p>Synthetic mRNAs (200 pg) encoding Sqt harboring multiple mutations from Activin&#x003b2;B (shown in red) were injected into wild-type and MZ<italic>oep</italic> embryos. <italic>gsc</italic> and <italic>ntl</italic> mRNA expression is shown at shield stage; animal pole views are dorsal to the right. Schematic is not drawn to scale. Note that the Sqt3 and Sqt5 constructs containing the Lys102&#x02013;X&#x02013;Asp104 motif and Asn99 insertion show weak expansion of <italic>ntl</italic> expression animally and dorsally in MZ<italic>oep</italic> mutants.</p></caption><graphic xlink:href="pbio.0020030.g006"/></fig></sec><sec id="s2h"><title>The Loop-&#x003b2;8 Region in Sqt Is Inhibitory </title><p>The results described above identified the loop-&#x003b2;8 region of Activin as a region that confers coreceptor-independent signaling to ligands that are normally EGF-CFC-dependent. In a reverse set of experiments, we asked which regions confer dependence on EGF-CFC coreceptors. To identify domains that confer EGF-CFC dependence, chimeras between Activin&#x003b2;B and Sqt (see Figures <xref ref-type="fig" rid="pbio-0020030-g004">4</xref> and <xref ref-type="fig" rid="pbio-0020030-g007">7</xref>) were analyzed for their inability to signal in MZ<italic>oep</italic> mutants. Chimeras containing the Sqt Finger 2 domain (AAS and ASS; see <xref ref-type="fig" rid="pbio-0020030-g004">Figure 4</xref>) or only the Sqt loop-&#x003b2;8 region (Act<sup>Sqt[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup>; <xref ref-type="fig" rid="pbio-0020030-g007">Figure 7</xref>) were inactive in both wild-type and MZ<italic>oep</italic> embryos. Western blot analysis demonstrated that these chimeras generate stable ligands (data not shown). The addition of Finger 1 in SAS or Act<sup>Sqt[Finger1-loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> relieved the inhibitory effect of the loop-&#x003b2;8 region of Sqt in wild-type embryos (<xref ref-type="fig" rid="pbio-0020030-g007">Figure 7</xref>). These chimeras were inactive in MZ<italic>oep</italic> mutants. These results indicate that the loop-&#x003b2;8 region in Sqt acts as an inhibitory domain and that Finger 1 relieves this inhibition by conferring dependence on EGF-CFC coreceptors.</p><fig id="pbio-0020030-g007" position="float"><label>Figure 7</label><caption><title>Sequence Determinants Conferring EGF-CFC Dependence</title><p>Synthetic mRNAs (200 pg) encoding Activin&#x003b2;B with single or double region substitutions from Sqt were injected into wild-type and MZ<italic>oep</italic> embryos. <italic>gsc</italic> and <italic>ntl</italic> mRNA expression is shown at shield stage; animal pole views are dorsal to the right. Schematic is not drawn to scale. HA indicates a hemagglutinin epitope tag. Note that Act<sup>Sqt[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> containing the loop-&#x003b2;8 region of Sqt is inactive in both wild-type and MZ<italic>oep</italic> embryos. In Act<sup>Sqt[Finger1-loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup>, the additional substitution of Sqt Finger 1 region relieves the inhibitory presence of the Sqt loop-&#x003b2;8 region. Similar to Sqt, Act<sup>Sqt[Finger1-loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> can induce ectopic <italic>gsc</italic> and <italic>ntl</italic> in wild-type, but not in MZ<italic>oep</italic> embryos. Western blot analysis indicates that these chimeric constructs produce stable ligands (data not shown).</p></caption><graphic xlink:href="pbio.0020030.g007"/></fig></sec><sec id="s2i"><title>Specificity of Antagonism by Lefty Is Determined by EGF-CFC Coreceptor Dependence</title><p>Our genetic and biochemical studies suggested that Lefty blocks Nodal and Vg1 signaling via EGF-CFC coreceptors. In contrast, the coreceptor-independent signaling by Activins cannot be blocked by Lefty. This finding predicts that the EGF-CFC-independent chimeric ligands Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup>, Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>A[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup>, and Vg1<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> should also be resistant to Lefty. Conversely, the coreceptor-dependent chimera Act<sup>Sqt[Finger1-loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> should be suspectible to inhibition by Lefty. To test this hypothesis, we coexpressed chimeric ligands and Lefty1 and analyzed <italic>gsc</italic> expression and A3-luc reporter induction (<xref ref-type="fig" rid="pbio-0020030-g008">Figure 8</xref>A&#x02013;<xref ref-type="fig" rid="pbio-0020030-g008">8</xref>M). As predicted, Lefty1 did not inhibit signaling by Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> (<xref ref-type="fig" rid="pbio-0020030-g008">Figure 8</xref>B and <xref ref-type="fig" rid="pbio-0020030-g008">8</xref>C), Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>A[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> (<xref ref-type="fig" rid="pbio-0020030-g008">Figure 8</xref>E and <xref ref-type="fig" rid="pbio-0020030-g008">8</xref>F), or Vg1<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> (<xref ref-type="fig" rid="pbio-0020030-g008">Figure 8</xref>H and <xref ref-type="fig" rid="pbio-0020030-g008">8</xref>I), but antagonized Act<sup>Sqt[Finger1-loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> (<xref ref-type="fig" rid="pbio-0020030-g008">Figure 8</xref>K and <xref ref-type="fig" rid="pbio-0020030-g008">8</xref>L). These results indicate that the incorporation of the Activin loop-&#x003b2;8 region into Nodal and Vg1 can render these ligands EGF-CFC-independent and therefore resistant to Lefty.</p><fig id="pbio-0020030-g008" position="float"><label>Figure 8</label><caption><title>EGF-CFC Coreceptor Depen-dence Determines Susceptibility to Antagonism by Lefty</title><p>(A&#x02013;L) Embryos were injected with 75 pg of <italic>Sqt<sup>Act&#x003b2;B[loop&#x003b2;8]</sup></italic> mRNA (A&#x02013;C), 75 pg of <italic>Sqt<sup>Act&#x003b2;A[<bold>loop</bold>&#x003b2;<bold>8</bold>]</sup></italic> mRNA (D&#x02013;F), 200 pg of <italic>Vg1<sup>Act&#x003b2;B[loop&#x003b2;8]</sup></italic> mRNA (G&#x02013;I), or 200 pg <italic>Act<sup>Sqt[Finger1-loop&#x003b2;8]</sup></italic> mRNA (J&#x02013;L). Embryos were further double-injected with either 500 pg of <italic>LacZ</italic> mRNA (A, D, G, and J), 100 pg of <italic>lefty1</italic> and 400 pg <italic>LacZ</italic> mRNAs (B, E, H, and K), or 500 pg of <italic>lefty1</italic> mRNA (C, F, I, and L). <italic>gsc</italic> mRNA expression in wild-type zebrafish embryos is shown at shield stage, animal pole view. Note that both levels of Lefty1 cannot inhibit the ectopic <italic>gsc</italic> expression induced by Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> (B and C), Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>A[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> (E and F), and Vg1<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> (H and I). In contrast, Lefty1 can inhibit Act<sup>Sqt[Finger1-loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> (K and L).</p><p>(M) Wild-type embryos were injected with 75 pg of either Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup>, Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>A[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup>, Vg1<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup>, or 200 pg of Act<sup>Sqt[Finger1-loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> mRNA. Embryos were further double-injected with 500 pg of <italic>LacZ</italic> mRNA, 100 pg of <italic>lefty1</italic>, and 400 pg of <italic>LacZ</italic> mRNAs, or 500 pg of <italic>lefty1</italic> mRNA. Smad2 pathway activation was measured by an Activin response element luciferase reporter, A3-luc. Values are folds over wild-type control injected with 500 pg of <italic>LacZ</italic> mRNA and A3-luc reporter. An asterisk indicates a significant difference from the level of activation with ligand and <italic>LacZ</italic> expression alone (Student's <italic>t</italic>-test, <italic>p</italic> &#x0003c; 0.05).</p></caption><graphic xlink:href="pbio.0020030.g008"/></fig></sec></sec><sec id="s3"><title>Discussion</title><sec><title>Lefty Antagonizes EGF-CFC Coreceptors</title><p>Lefty molecules are key regulators of mesendoderm development and left&#x02013;right axis determination, but the molecular basis of Lefty-mediated antagonism of Activin-like pathways has been elusive (<xref rid="pbio-0020030-Hamada1" ref-type="bibr">Hamada et al. 2002</xref>; <xref rid="pbio-0020030-Schier1" ref-type="bibr">Schier 2003</xref>). Our genetic and biochemical studies provide three lines of evidence that Lefty blocks EGF-CFC coreceptors. First, Lefty only inhibits EGF-CFC-dependent TGF&#x003b2; ligands such as Nodal and Vg1, but not EGF-CFC-independent ligands such as Activins. A striking example of this coreceptor-specific interaction is the finding that changing only 14 amino acids in Nodal or Vg1 to the corresponding residues in Activins renders the resulting TGF&#x003b2; ligands independent of EGF-CFC coreceptors and resistant to Lefty. Second, the EGF-CFC proteins mouse Cripto and zebrafish Oep can partially suppress the effects of Lefty overexpression in zebrafish. Third, Leftys can bind to EGF-CFC coreceptors and block the coreceptors from interacting with Nodal. Furthermore, Lefty/EGF-CFC complexes seem to exclude interactions with type I and type II Activin receptors. Taken together, these results indicate that Lefty blocks a subset of TGF&#x003b2; signals by the novel mechanism of blocking pathway-specific coreceptors (<xref ref-type="fig" rid="pbio-0020030-g009">Figure 9</xref>A&#x02013;<xref ref-type="fig" rid="pbio-0020030-g009">9</xref>D).</p><fig id="pbio-0020030-g009" position="float"><label>Figure 9</label><caption><title>Model for EGF-CFC, Activin Receptors, Lefty, and TGF&#x003b2; Interactions</title><p>(A) In the absence of ligands, the EGF-CFC coreceptor (solid pink) is constitutively bound to the type I receptor Alk4 (solid green).</p><p>(B) Nodal (solid blue) binds to receptor complexes consisting of EGF-CFC/Alk4 and ActRIIB (solid green).</p><p>(C) Lefty (solid yellow) sequesters the EGF-CFC coreceptor, thereby preventing Nodal binding to the receptor complexes.</p><p>(D) Subtle sequence differences determine the interaction with the EGF-CFC coreceptor and the Lefty inhibitor. Nodal and Vg1/GDF1 (solid blue) require the EGF-CFC coreceptor for signaling through ActRIIB and Alk4, while Activin (solid red) does not. Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> and Vg1<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> (solid blue with red strip) containing the loop-&#x003b2;8 region of Activin&#x003b2;B can bind to ActRIIB and Alk4 without the EGF-CFC coreceptor and therefore cannot be blocked by Lefty. Act<sup>Sqt[Finger1-loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup> (solid red with two blue strips) requires the coreceptor for receptor complex binding and can be inhibited by Lefty.</p></caption><graphic xlink:href="pbio.0020030.g009"/></fig><p>The observation that Lefty does not block signaling by Activin seems in apparent contrast to previous studies that led to naming some Lefty family members Antivins, for their anti-Activin properties (<xref rid="pbio-0020030-Thisse1" ref-type="bibr">Thisse and Thisse 1999</xref>; <xref rid="pbio-0020030-Cheng1" ref-type="bibr">Cheng et al. 2000</xref>; <xref rid="pbio-0020030-Ishimaru1" ref-type="bibr">Ishimaru et al. 2000</xref>; <xref rid="pbio-0020030-Tanegashima1" ref-type="bibr">Tanegashima et al. 2000</xref>). In particular, it has been found that misexpression of Activin can suppress the defects caused by Lefty misexpression in vivo (<xref rid="pbio-0020030-Thisse1" ref-type="bibr">Thisse and Thisse 1999</xref>). Our results do not undermine this finding, but suggest an alternative explanation. Previous studies have shown that Activin can suppress the loss of EGF-CFC activity in MZ<italic>oep</italic> mutants (<xref rid="pbio-0020030-Gritsman1" ref-type="bibr">Gritsman et al. 1999</xref>; <xref rid="pbio-0020030-Cheng2" ref-type="bibr">Cheng et al. 2003</xref>). Analogously, we suggest that the blocking of EGF-CFC activity by Lefty can be bypassed by Activin, because this ligand can activate Activin receptors independent of co-receptors. A similar scenario can also account for the suppression of Lefty gain-of-function phenotypes by misexpression and activation of Activin receptors (<xref rid="pbio-0020030-Meno4" ref-type="bibr">Meno et al. 1999</xref>; <xref rid="pbio-0020030-Thisse1" ref-type="bibr">Thisse and Thisse 1999</xref>; <xref rid="pbio-0020030-Sakuma1" ref-type="bibr">Sakuma et al. 2002</xref>). Hence, Activin and Activin receptors bypass the loss of EGF-CFC coreceptor function that is caused either by mutations in <italic>oep</italic> or by overexpression of Lefty. Conversely, Lefty cannot block Activin signals and Activin receptors because of their independence from EGF-CFC coreceptors.</p><p>Is the block of EGF-CFC coreceptors by Lefty a general and conserved mechanism? Although we have only analyzed a representative subset of these protein families (zebrafish and mouse Lefty1; zebrafish Oep; mouse Cripto; zebrafish Sqt), previous studies have suggested that heterologous Nodal, Lefty, and EGF-CFC proteins have similar activities in zebrafish (<xref rid="pbio-0020030-Schier1" ref-type="bibr">Schier 2003</xref>). For example, mouse Nodal, mouse Lefty2, and mouse Cripto are active in zebrafish, despite less than 30% overall sequence conservation with their zebrafish counterparts (<xref rid="pbio-0020030-Toyama1" ref-type="bibr">Toyama et al. 1995</xref>; <xref rid="pbio-0020030-Meno4" ref-type="bibr">Meno et al. 1999</xref>; <xref rid="pbio-0020030-Gritsman1" ref-type="bibr">Gritsman et al. 1999</xref>). These studies suggest that the molecular mechanisms described here apply to most, if not all, Nodal/Lefty/EGF-CFC interactions. This does not exclude the possibility that Lefty has additional means of blocking TGF&#x003b2; signaling. First, Leftys might block the processing of Nodals. However, Sqt is processed normally at levels of Lefty that block Nodal signaling (unpublished data). Second, Leftys might bind Nodal signals. This could result in blocking receptor interactions or antagonizing TGF&#x003b2; dimerization. However, Sqt is not bound by Lefty at Lefty levels that block Nodal signaling and lead to complex formation with Cripto (unpublished data). Moreover, a Sqt protein containing the loop-&#x003b2;8 region of Activin is resistant to Lefty, whereas changing only the dimerization residues in this region does not confer resistance. Third, Leftys might interact with additional extracellular factors. Indeed, the overexpression of the extracellular domain of the type II receptor ActRIIB has been shown to suppress Lefty activity (<xref rid="pbio-0020030-Meno4" ref-type="bibr">Meno et al. 1999</xref>). Although zebrafish Lefty1 does not appear to bind to ActRIIB, it is conceivable that overexpression of soluble ActRIIB might protect EGF-CFC coreceptors or another yet-to-be identified protein from antagonism by Lefty. In addition, overexpression of EGF-CFC proteins in zebrafish does not induce dominant phenotypes (<xref rid="pbio-0020030-Gritsman1" ref-type="bibr">Gritsman et al. 1999</xref>). It is therefore possible that an additional factor would be required to completely block Lefty in these experiments. Alternatively, overexpression levels of EGF-CFC coreceptors might not be high enough to block Lefty at blastula stages. It is also possible that coreceptor overexpression might block Nodal signals, because it has been shown that EGF-CFC proteins and Nodals can directly interact. The complex feedback interactions between Lefty and Nodal might also overcome an initial reduction of Lefty activity by increasing Lefty transcription. These considerations and the data presented here therefore suggest that a major, but perhaps not exclusive, role of Leftys is to block a subset of TGF&#x003b2; signals by interaction with EGF-CFC coreceptors.</p></sec><sec id="s3b"><title>Implications for the Role of Lefty during Development</title><p>Our finding that Leftys can block Vg1 signaling also has important implications for the developmental control of TGF&#x003b2; signaling. Based on previous studies revealing that Lefty proteins inhibit Nodal signaling, the mouse Lefty mutant phenotypes have been interpreted as a consequence of increased or sustained Nodal signaling (<xref rid="pbio-0020030-Hamada1" ref-type="bibr">Hamada et al. 2002</xref>; <xref rid="pbio-0020030-Schier1" ref-type="bibr">Schier 2003</xref>). For example, loss of mouse Lefty2 has been thought to increase Nodal signaling, resulting in an enlarged primitive streak (<xref rid="pbio-0020030-Meno4" ref-type="bibr">Meno et al. 1999</xref>). Similarly, the left&#x02013;right defects observed in mouse <italic>Lefty1</italic> and left-side specific <italic>Lefty2</italic> (<italic>Lefty2<sup>&#x00394;ASE</sup></italic>) mutants have been thought to be caused by inappropriate spread of Nodal signaling (<xref rid="pbio-0020030-Meno3" ref-type="bibr">Meno et al. 1998</xref>, 2001). Our finding that Vg1/GDF1 signaling can also be blocked by Lefty suggests a more complex scenario. In particular, GDF1 (the mouse homologue of Vg1) is required for proper left&#x02013;right axis determination (<xref rid="pbio-0020030-Rankin1" ref-type="bibr">Rankin et al. 2000</xref>). <italic>GDF1</italic> mutants appear to have the opposite phenotypes as <italic>Lefty1</italic> and <italic>Lefty2<sup>&#x00394;ASE</sup></italic> mutants. While GDF1 promotes the expression of left-side-specific genes such as <italic>Pitx2</italic> on the left, Leftys appear to block <italic>Pitx2</italic> expression on the right (<xref rid="pbio-0020030-Meno3" ref-type="bibr">Meno et al. 1998</xref>, 2001; <xref rid="pbio-0020030-Rankin1" ref-type="bibr">Rankin et al. 2000</xref>). In light of our findings, we suggest that during left&#x02013;right axis formation, Leftys act as antagonists of not only Nodal, but also GDF1. In this scenario, loss of Lefty1 or Lefty2 would lead to ectopic and sustained GDF1 signaling. This model is particularly attractive when one considers the expression patterns of <italic>Lefty1</italic>, <italic>Lefty2</italic>, the EGF-CFC gene <italic>Cryptic</italic>, <italic>Nodal</italic>, and <italic>GDF1. Lefty 1</italic> and <italic>GDF1</italic> are coexpressed in the developing midline (<xref rid="pbio-0020030-Meno1" ref-type="bibr">Meno et al. 1996</xref>, 1997; <xref rid="pbio-0020030-Rankin1" ref-type="bibr">Rankin et al. 2000</xref>), whereas <italic>Lefty2</italic> and <italic>Nodal</italic> are coexpressed in left-lateral plate mesoderm (<xref rid="pbio-0020030-Conlon2" ref-type="bibr">Conlon et al. 1994</xref>; <xref rid="pbio-0020030-Meno2" ref-type="bibr">Meno et al. 1997</xref>). <italic>Cryptic</italic> is expressed in both the lateral plate and midline (<xref rid="pbio-0020030-Shen3" ref-type="bibr">Shen et al. 1997</xref>). It is therefore conceivable that GDF1 signaling is restricted by Lefty1-mediated inhibition of Cryptic in the midline and its progenitors, whereas Nodal signaling is antagonized by Lefty2-mediated block of Cryptic in the lateral plate.</p><p>Our results might also have implications for the role of Cripto in tumorigenesis. Cripto is highly overexpressed in human epithelial cancers, such as breast and colon carcinomas (<xref rid="pbio-0020030-Salomon1" ref-type="bibr">Salomon et al. 2000</xref>), and has been implicated in tumor formation (<xref rid="pbio-0020030-Ciardiello1" ref-type="bibr">Ciardiello et al. 1991</xref>, 1994; <xref rid="pbio-0020030-Baldassarre1" ref-type="bibr">Baldassarre et al. 1996</xref>; <xref rid="pbio-0020030-De1" ref-type="bibr">De Luca et al. 2000</xref>; <xref rid="pbio-0020030-Salomon1" ref-type="bibr">Salomon et al. 2000</xref>; <xref rid="pbio-0020030-Adkins1" ref-type="bibr">Adkins et al. 2003</xref>). Although the mechanisms by which Cripto acts in these circumstances are unclear, inhibition of Cripto by antisense or antibody blockade can inhibit tumor cell proliferation (<xref rid="pbio-0020030-Ciardiello2" ref-type="bibr">Ciardiello et al. 1994</xref>; <xref rid="pbio-0020030-Baldassarre1" ref-type="bibr">Baldassarre et al. 1996</xref>; <xref rid="pbio-0020030-De1" ref-type="bibr">De Luca et al. 2000</xref>; <xref rid="pbio-0020030-Adkins1" ref-type="bibr">Adkins et al. 2003</xref>; reviewed by <xref rid="pbio-0020030-Shen1" ref-type="bibr">Shen 2003</xref>). Since Lefty is an in vivo antagonist of EGF-CFC activity, it might also serve as a therapeutic agent to block Cripto.</p></sec><sec id="s3c"><title>Subtle Sequence Differences Determine the Interaction with Coreceptors and Inhibitors</title><p>The finding that the highly related ligands Activin, Nodal, and Vg1/GDF1 activate the same receptors but differ in their dependence on coreceptors allowed us to determine how ligand diversity and signaling specificity can be achieved. We have identified the loop-&#x003b2;8 region as a 14 amino acid domain, a mere 4% of the entire TGF&#x003b2; signal, that contributes to coreceptor dependence or independence. Sqt and Vg1 incorporating the loop-&#x003b2;8 region of Activin can bind to the Activin receptors in the absence of EGF-CFC proteins. Conversely, Activin incorporating the loop-&#x003b2;8 region of Sqt is inactive, suggesting that the Nodal/Vg1 loop-&#x003b2;8 region might be inhibitory. This inhibition can be relieved by the Finger 1 domain of Sqt, which results in the dependence on EGF-CFC coreceptors (<xref ref-type="fig" rid="pbio-0020030-g009">Figure 9</xref>D). These results indicate that rather subtle sequence variations can lead to striking changes in ligand diversity.</p><p>Structural considerations suggest that the loop-&#x003b2;8 region determines coreceptor independence or dependence at least in part by its interactions with type II receptors. The conserved Lys102&#x02013;X&#x02013;Asp104 motif in the Activin loop-&#x003b2;8 region has been shown to be important for high-affinity binding to the ActRII receptor (<xref rid="pbio-0020030-Wuytens1" ref-type="bibr">Wuytens et al. 1999</xref>; <xref rid="pbio-0020030-Greenwald1" ref-type="bibr">Greenwald et al. 2003</xref>; <xref rid="pbio-0020030-Thompson1" ref-type="bibr">Thompson et al. 2003</xref>). In the crystal structure of the Activin&#x003b2;A-ActRIIB complex, Lys102&#x02013;X&#x02013;Asp104 forms an intramolecular salt bridge that interacts with a hydrophobic interface on ActRIIB (<xref rid="pbio-0020030-Thompson1" ref-type="bibr">Thompson et al. 2003</xref>). Mutational analysis has shown that substituting Lys102 with a neutral charge (Ala) significantly reduces receptor binding affinity and signaling (<xref rid="pbio-0020030-Wuytens1" ref-type="bibr">Wuytens et al. 1999</xref>). In contrast to Activin, EGF-CFC-dependent ligands such as Nodals and Vg1/GDF1 have the differentially charged residues Met/Leu102 and His104 at the corresponding positions (numbering according to Activin&#x003b2;A). Similarly, in BMP7 the corresponding residues are Leu102 and Lys104. It has been shown that modeling Lys onto the aligned 102 residue in BMP7 positions it within hydrogen-bonding distance to Glu29 of ActRII and may allow for greater hydrophobic packing at the interface (<xref rid="pbio-0020030-Greenwald1" ref-type="bibr">Greenwald et al. 2003</xref>). Analogously, we propose that Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>A[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup>, Sqt<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup>,Vg1<sup>Act</sup>
<sup>&#x003b2;</sup>
<sup>B[loop</sup>
<sup>&#x003b2;</sup>
<sup>8]</sup>, Sqt3, and Sqt5 are coreceptor-independent because of their favorable binding to ActRIIB receptors. Conversely, the corresponding region in Sqt and Vg1 might be inhibitory because of inefficient interaction with ActRIIB receptors. Detailed structural studies should reveal whether EGF-CFC proteins overcome this inhibition by changing the conformation of Nodal and Vg1 or by providing an additional interaction surface that allows the assembly of receptor complexes.</p><p>In summary, our results lead to two major conclusions. First, Lefty inhibits a subset of TGF&#x003b2; signals by using the novel mechanism of blocking pathway-specific coreceptors belonging to the EGF-CFC family. Second, subtle sequence changes in TGF&#x003b2;s determine their signaling specificity and dependence on coreceptors. Although <italic>Drosophila</italic> has an Activin signaling pathway, Nodals, Leftys, and EGF-CFC proteins seem to be restricted to chordates (<xref rid="pbio-0020030-Brummel1" ref-type="bibr">Brummel et al. 1999</xref>; <xref rid="pbio-0020030-Schier1" ref-type="bibr">Schier 2003</xref>). The evolution of Activin-like signaling pathways therefore represents a remarkable example of how a simple signaling pathway consisting of ligand and receptors can be diversified by subtle sequence changes that modulate the interaction with coreceptors and their inhibitors.</p></sec></sec><sec id="s4"><title>Materials and Methods</title><sec id="s4a"><title/><sec id="s4a1"><title>Strains and embryos.</title><p>Adult homozygous fish for <italic>oep<sup>tz57</sup></italic> were generated as described previously (<xref rid="pbio-0020030-Zhang1" ref-type="bibr">Zhang et al. 1998</xref>; <xref rid="pbio-0020030-Gritsman1" ref-type="bibr">Gritsman et al. 1999</xref>). <italic>Xenopus</italic> embryos were obtained as described in <xref rid="pbio-0020030-Hemmati-Brivanlou2" ref-type="bibr">Hemmati-Brivanlou et al. (1992</xref>).</p></sec><sec id="s4a2"><title>Generation of constructs.</title><p>Epitope-tagged and chimeric constructs were made using PCR-based methods and confirmed by sequencing. pCS2-zebrafish Lefty1/HA and Lefty1/Glu constructs were generated by inserting three tandem copies of HA-epitope or Glu-epitope, respectively, after Val145. The initial three-lettered (XXX) Sqt/Activin&#x003b2;B chimeras were generated by subcloning the prodomain of <italic>Xenopus</italic> Activin&#x003b2;B (codons Met1 to Gly256) fused to an HA-epitope/XhoI fragment (YPYDVPDYALE) and followed by the mature chimeric ligand into pcDNA3 vector. <italic>S</italic> denotes Sqt; <italic>A</italic> denotes Activin&#x003b2;B. The boundaries for Sqt mature ligand domains are as indicated: Finger 1 (Asn263 to Cys325), Heel (Pro326 to Cys358), and Finger 2 (Val359 to His392). The boundaries for <italic>Xenopus</italic> Activin&#x003b2;B mature ligand domains are as indicated: Finger 1 (Cys215 to Cys299), Heel (Pro300 to Cys335), and Finger 2 (Ile336 to Ala370). Full-length chimeras were generated by incorporating the indicated regions into Sqt, Activin&#x003b2;B, or zebrafish Vg1, which were then subcloned into the pT<sub>7</sub>T<sub>S</sub> vector (<xref rid="pbio-0020030-Ekker1" ref-type="bibr">Ekker et al. 1995</xref>). The boundaries for Sqt Finger 2 structural subregions are as indicated: &#x003b2;6&#x003b2;7 (Val359 to Try370), loop (Tyr371 to Met376), &#x003b2;8 (Val377 to Gly383), and &#x003b2;9 (Met384 to His392). The boundaries for <italic>Xenopus</italic> Activin&#x003b2;B Finger 2 structural subregions are as indicated: &#x003b2;6&#x003b2;7 (Ile336 to Try347), loop (Phe348 to Ile354), &#x003b2;8 (Val355 to Asn356), and &#x003b2;9 (Met357 to Ala370). The <italic>Xenopus</italic> Activin&#x003b2;A loop-&#x003b2;8 region sequence is FDRNNNVLKTDIAD (also identical in <italic>Xenopus</italic> Activin&#x003b2;D). The zebrafish Vg1 loop-&#x003b2;8 region is from Try332 to Asp345. pcDNA3-zebrafish Vg1/HA, pcDNA3-Squint/HA, pCS2-Alk4(KR)/Flag (a kinase-defective mutant of human Alk4 with Lys234 to Arg234 substitution), pCS2-ActRIIB(KR)/Myc (a kinase-defective mutant of mouse ActRIIB with Lys217 to Arg217 substitution), and pCS2-Cripto/Flag have been described elsewhere (<xref rid="pbio-0020030-Yeo1" ref-type="bibr">Yeo and Whitman 2001</xref>; <xref rid="pbio-0020030-Cheng2" ref-type="bibr">Cheng et al. 2003</xref>).</p></sec><sec id="s4a3"><title>Embryo microinjection.</title><p>Plasmids were linearized and sense strand-capped mRNA was synthesized using the mMESSAGE mMACHINE system (Ambion, Austin, Texas, United States). Zebrafish embryos were dechorinated by pronase treatment and injected between the one- and four-cell stage. <italic>Xenopus</italic> embryos at the one- to two-cell stage were used for injections into the animal pole.</p></sec><sec id="s4a4"><title>Phenotypic analysis.</title><p>Zebrafish embryos at 24 h were mounted in 2% methylcellulose and photographed using a Zeiss (Oberkochen, Germany) M2Bio dissecting microscope. In situ hybrization was performed as described previously (<xref rid="pbio-0020030-Thisse2" ref-type="bibr">Thisse et al. 1993</xref>), using RNA probes to <italic>gsc</italic> and <italic>ntl</italic> (<xref rid="pbio-0020030-Stachel1" ref-type="bibr">Stachel et al. 1993</xref>; <xref rid="pbio-0020030-Schulte-Merker1" ref-type="bibr">Schulte-Merker et al. 1994</xref>).</p></sec><sec id="s4a5"><title>Luciferase reporter assay.</title><p>Luciferase assays were performed with three to six samples and five embryos in each sample. Results are representative of three independent experiments. The injection mixtures were equalized with respect to total mRNA amount with <italic>LacZ</italic> mRNA. The A3-luc reporter DNA construct (25 pg) (<xref rid="pbio-0020030-Chen1" ref-type="bibr">Chen et al. 1996</xref>) was also coinjected. Whole zebrafish embryos were harvested at shield stage. Luciferase activity was analyzed using the Luciferase Reporter Assay system (Promega, Madison, Wisconsin, United States) according to the manufacturer's instruction in a Lumat LB9501 (Berthold Technologies, Bad Wildbad, Germany). Owing to the technical aspects of microinjections, in rare circumstances, a single outlier was statistically removed from a population using Grubbs' test/extreme studentized deviate method. Inclusion of outliers into the populations does not change the statistical significance of the <italic>p</italic> values; that is, <italic>p</italic> remains &#x0003c;0.05, where indicated.</p></sec><sec id="s4a6"><title>Coimmunoprecipitation analysis.</title><p>
<italic>Xenopus</italic> embryos were harvested at stage 10. For chemical cross-linking of proteins, animal halves were incubated in PBS with 10 mM 3,3&#x02032;-dithiobis(sulfo-succinimidyl propionate) (DTSSP) (Pierce Biotechnology, Rockford, Illinois, United States) and incubated for 2 h on ice. Coimmunoprecipitation was performed as described previously (<xref rid="pbio-0020030-Yeo1" ref-type="bibr">Yeo and Whitman 2001</xref>). Purified processed mouse Lefty1, soluble mouse Cripto, and mouse VEGF-D proteins were obtained from R&#x00026;D Systems (Minneapolis, Minnesota, United States). Activity assays were performed by R&#x00026;D Systems. The proteins were incubated in PBS with 1 mM DTSSP for 1 h on ice. Coimmunoprecipitation was performed as described previously (<xref rid="pbio-0020030-Yeo1" ref-type="bibr">Yeo and Whitman 2001</xref>). Samples were treated with 100 mM DTT to cleave DTSSP prior to SDS-PAGE analysis. The following antibodies were used for immunoprecipitation and Western blot analysis: anti-Flag mouse monoclonal antibody (clone M2; Sigma, St. Louis, Missouri, United States), anti-HA mouse monoclonal antibody (clone 16B12; Covance, Princeton, New Jersey, United States), anti-HA rabbit polyclonal antibody (Y-11; Santa Cruz Biotechnology, Santa Cruz, California, United States), anti-c-Myc rabbit polyclonal antibody (A-14; Santa Cruz Biotechnology), anti-c-Myc mouse monoclonal antibody (clone Ab-1; Oncogene Science, Tarrytown, New York, United States), anti-His mouse monoclonal antibody (clone 6-His; Covance), anti-mLefty1 goat polyclonal antibody (R&#x00026;D Systems), and anti-Glu mouse monoclonal antibody (clone Glu-Glu; Covance). Proteins were visualized using the Super Signal West Pico/Femto Chemiluminescent Substrate system (Pierce).</p></sec></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><sec id="s5a"><title>Accession Numbers</title><p>The GenBank (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fc-gi?db=Nucleotide">http://www.ncbi.nlm.nih.gov/entrez/query.fc-gi?db=Nucleotide</ext-link>) accession numbers for the sequences discussed in this paper are Activin&#x003b2;A (Q9W6I6), Activin&#x003b2;B (Q91350), human ActRIIB (P08476), mouse ActRIIB (P27040), rat ActRIIB (P38445), Alk4 (Z22536), BMP7 (P23359), Cripto (P51865), Cryptic (P97766), <italic>cyclops</italic> (P87358), GDF1 (P20863), <italic>goosecoid</italic> (P53544), Lefty1 (Q9W6I6), Lefty2 (P57785), mLefty1 (Q64280), Nodal (P43021), <italic>no tail</italic> (Q07998), <italic>one-eyed pinhead</italic> (O57516), <italic>Pitx2</italic> (P97474), <italic>squint</italic> (O13144), VEGF-D (P97946), and Vg1 (P09534).</p></sec></sec></body><back><ack><p>We thank members of the Schier, Brivanlou, and Yelon laboratories for discussions; Gord Fishell, Kathy Joubin, Alvaro Sagasti, and Will Talbot for comments on the manuscript; Steven Zimmerman, Trisha Bruno, and Nicole Dillon for fish care; Chang-Yeol Yeo and Malcolm Whitman for sharing of plasmids and protocols; and Matthieu Schapira for aiding with structural modeling. SKC was supported in part by National Institutes of Health (NIH) training grant T32HD07520. AHB is supported by the NIH. AFS is a Scholar of the McKnight Endowment Fund for Neuroscience, a Irma T. Hirschl Trust Career Scientist, and an Established Investigator of the American Heart Association and is supported by grants from the NIH.</p></ack><fn-group><fn id="n1" fn-type="COI-statement"><p>
<bold>Conflicts of interest.</bold> The authors have declared that no conflicts of interest exist.</p></fn><fn id="n2" fn-type="con"><p>
<bold>Author contributions.</bold> SKC, AHB, and AFS conceived and designed the experiments. SKC and FO performed the experiments. SKC, FO, AHB, and AFS analyzed the data. SKC, FO, AHB, and AFS contributed reagents/materials/analysis tools. SKC and AFS wrote the paper.</p></fn></fn-group><fn-group><fn id="n3"><p>DOI: <ext-link ext-link-type="doi" xlink:href="10.1371/journal.pbio.0020030">10.1371/journal.pbio.0020030</ext-link>
</p></fn><fn id="n4"><p>Copyright: &#x000a9;&#x02009;2004 Cheng et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></fn><fn id="n5" fn-type="edited-by"><p>Academic Editor: Hiroshi Hamada, Osaka University</p></fn></fn-group><ref-list><title>References</title><ref id="pbio-0020030-Adkins1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adkins</surname><given-names>HB</given-names></name><name><surname>Bianco</surname><given-names>C</given-names></name><name><surname>Schiffer</surname><given-names>SG</given-names></name><name><surname>Rayhorn</surname><given-names>P</given-names></name><name><surname>Zafari</surname><given-names>M</given-names></name><etal/></person-group><article-title>Antibody blockade of the Cripto CFC domain suppresses tumor cell growth <italic>in vivo</italic>
</article-title><source>J Clin Invest</source><year>2003</year><volume>112</volume><fpage>575</fpage><lpage>587</lpage><pub-id pub-id-type="pmid">12925698</pub-id></element-citation></ref><ref id="pbio-0020030-Agathon1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agathon</surname><given-names>A</given-names></name><name><surname>Thisse</surname><given-names>B</given-names></name><name><surname>Thisse</surname><given-names>C</given-names></name></person-group><article-title>Morpholino knock-down of <italic>antivin1</italic> and <italic>antivin2</italic> upregulates <italic>nodal</italic> signaling</article-title><source>Genesis</source><year>2001</year><volume>30</volume><fpage>178</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">11477702</pub-id></element-citation></ref><ref id="pbio-0020030-Attisano1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attisano</surname><given-names>L</given-names></name><name><surname>Wrana</surname><given-names>JL</given-names></name><name><surname>Cheifetz</surname><given-names>S</given-names></name><name><surname>Massague</surname><given-names>J</given-names></name></person-group><article-title>Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors</article-title><source>Cell</source><year>1992</year><volume>68</volume><fpage>97</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">1310075</pub-id></element-citation></ref><ref id="pbio-0020030-Attisano2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attisano</surname><given-names>L</given-names></name><name><surname>Wrana</surname><given-names>JL</given-names></name><name><surname>Montalvo</surname><given-names>E</given-names></name><name><surname>Massague</surname><given-names>J</given-names></name></person-group><article-title>Activation of signalling by the activin receptor complex</article-title><source>Mol Cell Biol</source><year>1996</year><volume>16</volume><fpage>1066</fpage><lpage>1073</lpage><pub-id pub-id-type="pmid">8622651</pub-id></element-citation></ref><ref id="pbio-0020030-Baldassarre1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldassarre</surname><given-names>G</given-names></name><name><surname>Bianco</surname><given-names>C</given-names></name><name><surname>Tortora</surname><given-names>G</given-names></name><name><surname>Ruggiero</surname><given-names>A</given-names></name><name><surname>Moasser</surname><given-names>M</given-names></name><etal/></person-group><article-title>Transfection with a CRIPTO anti-sense plasmid suppresses endogenous CRIPTO expression and inhibits transformation in a human embryonal carcinoma cell line</article-title><source>Int J Cancer</source><year>1996</year><volume>66</volume><fpage>538</fpage><lpage>543</lpage><pub-id pub-id-type="pmid">8635871</pub-id></element-citation></ref><ref id="pbio-0020030-Bamford1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bamford</surname><given-names>RN</given-names></name><name><surname>Roessler</surname><given-names>E</given-names></name><name><surname>Burdine</surname><given-names>RD</given-names></name><name><surname>Saplakoglu</surname><given-names>U</given-names></name><name><surname>de la Cruz</surname><given-names>J</given-names></name><etal/></person-group><article-title>Loss-of-function mutations in the EGF-CFC gene <italic>CFC1</italic> are associated with human left&#x02013;right laterality defects</article-title><source>Nat Genet</source><year>2000</year><volume>26</volume><fpage>365</fpage><lpage>369</lpage><pub-id pub-id-type="pmid">11062482</pub-id></element-citation></ref><ref id="pbio-0020030-Bianco1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianco</surname><given-names>C</given-names></name><name><surname>Adkins</surname><given-names>HB</given-names></name><name><surname>Wechselberger</surname><given-names>C</given-names></name><name><surname>Seno</surname><given-names>M</given-names></name><name><surname>Normanno</surname><given-names>N</given-names></name><etal/></person-group><article-title>Cripto-1 activates <italic>nodal</italic>- and <italic>ALK4</italic>-dependent and -independent signaling pathways in mammary epithelial cells</article-title><source>Mol Cell Biol</source><year>2002</year><volume>22</volume><fpage>2586</fpage><lpage>2597</lpage><pub-id pub-id-type="pmid">11909953</pub-id></element-citation></ref><ref id="pbio-0020030-Bianco2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianco</surname><given-names>C</given-names></name><name><surname>Strizzi</surname><given-names>L</given-names></name><name><surname>Rehman</surname><given-names>A</given-names></name><name><surname>Normanno</surname><given-names>N</given-names></name><name><surname>Wechselberger</surname><given-names>C</given-names></name><etal/></person-group><article-title>A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src</article-title><source>Cancer Res</source><year>2003</year><volume>636</volume><fpage>1192</fpage><lpage>1197</lpage></element-citation></ref><ref id="pbio-0020030-Bisgrove1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bisgrove</surname><given-names>BW</given-names></name><name><surname>Essner</surname><given-names>JJ</given-names></name><name><surname>Yost</surname><given-names>HJ</given-names></name></person-group><article-title>Regulation of midline development by antagonism of lefty and nodal signaling</article-title><source>Development</source><year>1999</year><volume>126</volume><fpage>3253</fpage><lpage>3262</lpage><pub-id pub-id-type="pmid">10375514</pub-id></element-citation></ref><ref id="pbio-0020030-Branford1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branford</surname><given-names>WW</given-names></name><name><surname>Yost</surname><given-names>HJ</given-names></name></person-group><article-title>Lefty-dependent inhibition of <italic>nodal</italic>- and <italic>wnt</italic>-responsive organizer gene expression is essential for normal gastrulation</article-title><source>Curr Biol</source><year>2002</year><volume>12</volume><fpage>2136</fpage><lpage>2141</lpage><pub-id pub-id-type="pmid">12498689</pub-id></element-citation></ref><ref id="pbio-0020030-Branford2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branford</surname><given-names>WW</given-names></name><name><surname>Essner</surname><given-names>JJ</given-names></name><name><surname>Yost</surname><given-names>HJ</given-names></name></person-group><article-title>Regulation of gut and heart left&#x02013;right asymmetry by context-dependent interactions between <named-content content-type="genus-species">Xenopus lefty</named-content> and <italic>BMP4</italic> signaling</article-title><source>Dev Biol</source><year>2000</year><volume>223</volume><fpage>291</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">10882517</pub-id></element-citation></ref><ref id="pbio-0020030-Brennan1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>J</given-names></name><name><surname>Norris</surname><given-names>DP</given-names></name><name><surname>Robertson</surname><given-names>EJ</given-names></name></person-group><article-title>Nodal activity in the node governs left&#x02013;right asymmetry</article-title><source>Genes Dev</source><year>2002</year><volume>16</volume><fpage>2339</fpage><lpage>2344</lpage><pub-id pub-id-type="pmid">12231623</pub-id></element-citation></ref><ref id="pbio-0020030-Brummel1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brummel</surname><given-names>T</given-names></name><name><surname>Abdollah</surname><given-names>S</given-names></name><name><surname>Haerry</surname><given-names>TE</given-names></name><name><surname>Shimell</surname><given-names>MJ</given-names></name><name><surname>Merriam</surname><given-names>J</given-names></name><etal/></person-group><article-title>The <italic>Drosophila</italic> activin receptor baboon signals through dSmad2 and controls cell proliferation but not patterning during larval development</article-title><source>Genes Dev</source><year>1999</year><volume>13</volume><fpage>98</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">9887103</pub-id></element-citation></ref><ref id="pbio-0020030-Chang1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>C</given-names></name><name><surname>Wilson</surname><given-names>PA</given-names></name><name><surname>Mathews</surname><given-names>LS</given-names></name><name><surname>Hemmati-Brivanlou</surname><given-names>A</given-names></name></person-group><article-title>A <italic>Xenopus</italic> type I activin receptor mediates mesodermal but not neural specification during embryogenesis</article-title><source>Development</source><year>1997</year><volume>124</volume><fpage>827</fpage><lpage>837</lpage><pub-id pub-id-type="pmid">9043064</pub-id></element-citation></ref><ref id="pbio-0020030-Chen1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Rubock</surname><given-names>MJ</given-names></name><name><surname>Whitman</surname><given-names>M</given-names></name></person-group><article-title>A transcriptional partner for MAD proteins in TGF-beta signalling</article-title><source>Nature</source><year>1996</year><volume>383</volume><fpage>691</fpage><lpage>696</lpage><pub-id pub-id-type="pmid">8878477</pub-id></element-citation></ref><ref id="pbio-0020030-Chen2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><article-title>The zebrafish Nodal signal Squint functions as a morphogen</article-title><source>Nature</source><year>2001</year><volume>411</volume><fpage>607</fpage><lpage>610</lpage><pub-id pub-id-type="pmid">11385578</pub-id></element-citation></ref><ref id="pbio-0020030-Chen3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><article-title>Lefty proteins are long-range inhibitors of <italic>squint</italic>-mediated <italic>nodal</italic> signaling</article-title><source>Curr Biol</source><year>2002</year><volume>12</volume><fpage>2124</fpage><lpage>2128</lpage><pub-id pub-id-type="pmid">12498687</pub-id></element-citation></ref><ref id="pbio-0020030-Cheng1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>AM</given-names></name><name><surname>Thisse</surname><given-names>B</given-names></name><name><surname>Thisse</surname><given-names>C</given-names></name><name><surname>Wright</surname><given-names>CV</given-names></name></person-group><article-title>The <italic>lefty</italic>-related factor <italic>Xatv</italic> acts as a feedback inhibitor of <italic>nodal</italic> signaling in mesoderm induction and L&#x02013;R axis development in <italic>Xenopus</italic>
</article-title><source>Development</source><year>2000</year><volume>127</volume><fpage>1049</fpage><lpage>1061</lpage><pub-id pub-id-type="pmid">10662644</pub-id></element-citation></ref><ref id="pbio-0020030-Cheng2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>SK</given-names></name><name><surname>Olale</surname><given-names>F</given-names></name><name><surname>Bennett</surname><given-names>JT</given-names></name><name><surname>Brivanlou</surname><given-names>AH</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><article-title>EGF-CFC proteins are essential coreceptors for the TGF-beta signals Vg1 and GDF1</article-title><source>Genes Dev</source><year>2003</year><volume>17</volume><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">12514096</pub-id></element-citation></ref><ref id="pbio-0020030-Ciardiello1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciardiello</surname><given-names>F</given-names></name><name><surname>Dono</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name><name><surname>Persico</surname><given-names>MG</given-names></name><name><surname>Salomon</surname><given-names>DS</given-names></name></person-group><article-title>Expression of <italic>cripto</italic>, a novel gene of the epidermal growth factor gene family, leads to <italic>in vitro</italic> transformation of a normal mouse mammary epithelial cell line</article-title><source>Cancer Res</source><year>1991</year><volume>51</volume><fpage>1051</fpage><lpage>1054</lpage><pub-id pub-id-type="pmid">1846316</pub-id></element-citation></ref><ref id="pbio-0020030-Ciardiello2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciardiello</surname><given-names>F</given-names></name><name><surname>Tortora</surname><given-names>G</given-names></name><name><surname>Bianco</surname><given-names>C</given-names></name><name><surname>Selvam</surname><given-names>MP</given-names></name><name><surname>Basolo</surname><given-names>F</given-names></name><etal/></person-group><article-title>Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides</article-title><source>Oncogene</source><year>1994</year><volume>9</volume><fpage>291</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">8302592</pub-id></element-citation></ref><ref id="pbio-0020030-Conlon1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conlon</surname><given-names>FL</given-names></name><name><surname>Barth</surname><given-names>KS</given-names></name><name><surname>Robertson</surname><given-names>EJ</given-names></name></person-group><article-title>A novel retrovirally induced embryonic lethal mutation in the mouse: Assessment of the developmental fate of embryonic stem cells homozygous for the 413.d proviral integration</article-title><source>Development</source><year>1991</year><volume>111</volume><fpage>969</fpage><lpage>981</lpage><pub-id pub-id-type="pmid">1879365</pub-id></element-citation></ref><ref id="pbio-0020030-Conlon2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conlon</surname><given-names>FL</given-names></name><name><surname>Lyons</surname><given-names>KM</given-names></name><name><surname>Takaesu</surname><given-names>N</given-names></name><name><surname>Barth</surname><given-names>KS</given-names></name><name><surname>Kispert</surname><given-names>A</given-names></name><etal/></person-group><article-title>A primary requirement for <italic>nodal</italic> in the formation and maintenance of the primitive streak in the mouse</article-title><source>Development</source><year>1994</year><volume>120</volume><fpage>1919</fpage><lpage>1928</lpage><pub-id pub-id-type="pmid">7924997</pub-id></element-citation></ref><ref id="pbio-0020030-De1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Luca</surname><given-names>A</given-names></name><name><surname>Arra</surname><given-names>C</given-names></name><name><surname>D'Antonio</surname><given-names>A</given-names></name><name><surname>Casamassimi</surname><given-names>A</given-names></name><name><surname>Losito</surname><given-names>S</given-names></name><etal/></person-group><article-title>Simultaneous blockage of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts</article-title><source>Oncogene</source><year>2000</year><volume>19</volume><fpage>5863</fpage><lpage>5871</lpage><pub-id pub-id-type="pmid">11127817</pub-id></element-citation></ref><ref id="pbio-0020030-De2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Robertis</surname><given-names>EM</given-names></name><name><surname>Wessely</surname><given-names>O</given-names></name><name><surname>Oelgeschlager</surname><given-names>M</given-names></name><name><surname>Brizuela</surname><given-names>B</given-names></name><name><surname>Pera</surname><given-names>E</given-names></name><etal/></person-group><article-title>Molecular mechanisms of cell&#x02013;cell signaling by the Spemann&#x02013;Mangold organizer</article-title><source>Int J Dev Biol</source><year>2001</year><volume>45</volume><fpage>189</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">11291846</pub-id></element-citation></ref><ref id="pbio-0020030-Ding1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Yan</surname><given-names>YT</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><name><surname>Desai</surname><given-names>N</given-names></name><etal/></person-group><article-title>Cripto is required for correct orientation of the anterior&#x02013;posterior axis in the mouse embryo</article-title><source>Nature</source><year>1998</year><volume>395</volume><fpage>702</fpage><lpage>707</lpage><pub-id pub-id-type="pmid">9790191</pub-id></element-citation></ref><ref id="pbio-0020030-Ebert1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebert</surname><given-names>AD</given-names></name><name><surname>Wechselberger</surname><given-names>C</given-names></name><name><surname>Frank</surname><given-names>S</given-names></name><name><surname>Wallace-Jones</surname><given-names>B</given-names></name><name><surname>Seno</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cripto-1 induces phosphatidylinositol 3&#x02032;-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3&#x003b2; in human cervical carcinoma cells</article-title><source>Cancer Res</source><year>1999</year><volume>59</volume><fpage>4502</fpage><lpage>4505</lpage><pub-id pub-id-type="pmid">10493495</pub-id></element-citation></ref><ref id="pbio-0020030-Ekker1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekker</surname><given-names>SC</given-names></name><name><surname>Ungar</surname><given-names>AR</given-names></name><name><surname>Greenstein</surname><given-names>P</given-names></name><name><surname>von Kessler</surname><given-names>DP</given-names></name><name><surname>Porter</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Patterning activities of vertebrate <italic>hedgehog</italic> proteins in the developing eye and brain</article-title><source>Curr Biol</source><year>1995</year><volume>5</volume><fpage>944</fpage><lpage>955</lpage><pub-id pub-id-type="pmid">7583153</pub-id></element-citation></ref><ref id="pbio-0020030-Erter1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erter</surname><given-names>CE</given-names></name><name><surname>Solnica-Krezel</surname><given-names>L</given-names></name><name><surname>Wright</surname><given-names>CV</given-names></name></person-group><article-title>Zebrafish <italic>nodal-related 2</italic> encodes an early mesendodermal inducer signaling from the extraembryonic yolk syncytial layer</article-title><source>Dev Biol</source><year>1998</year><volume>204</volume><fpage>361</fpage><lpage>372</lpage><pub-id pub-id-type="pmid">9882476</pub-id></element-citation></ref><ref id="pbio-0020030-Feldman1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman</surname><given-names>B</given-names></name><name><surname>Gates</surname><given-names>MA</given-names></name><name><surname>Egan</surname><given-names>ES</given-names></name><name><surname>Dougan</surname><given-names>ST</given-names></name><name><surname>Rennebeck</surname><given-names>G</given-names></name><etal/></person-group><article-title>Zebrafish organizer development and germ-layer formation require <italic>nodal</italic>-related signals</article-title><source>Nature</source><year>1998</year><volume>395</volume><fpage>181</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">9744277</pub-id></element-citation></ref><ref id="pbio-0020030-Feldman2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman</surname><given-names>B</given-names></name><name><surname>Concha</surname><given-names>ML</given-names></name><name><surname>Saude</surname><given-names>L</given-names></name><name><surname>Parsons</surname><given-names>MJ</given-names></name><name><surname>Adams</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>Lefty antagonism of <italic>squint</italic> is essential for normal gastrulation</article-title><source>Curr Biol</source><year>2002</year><volume>12</volume><fpage>2129</fpage><lpage>2135</lpage><pub-id pub-id-type="pmid">12498688</pub-id></element-citation></ref><ref id="pbio-0020030-Freeman1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>M</given-names></name></person-group><article-title>Feedback control of intercellular signalling in development</article-title><source>Nature</source><year>2000</year><volume>408</volume><fpage>313</fpage><lpage>319</lpage><pub-id pub-id-type="pmid">11099031</pub-id></element-citation></ref><ref id="pbio-0020030-Gaio1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaio</surname><given-names>U</given-names></name><name><surname>Schweickert</surname><given-names>A</given-names></name><name><surname>Fischer</surname><given-names>A</given-names></name><name><surname>Garratt</surname><given-names>AN</given-names></name><name><surname>Muller</surname><given-names>T</given-names></name><etal/></person-group><article-title>A role of the <italic>cryptic</italic> gene in the correct establishment of the left&#x02013;right axis</article-title><source>Curr Biol</source><year>1999</year><volume>9</volume><fpage>1339</fpage><lpage>1342</lpage><pub-id pub-id-type="pmid">10574770</pub-id></element-citation></ref><ref id="pbio-0020030-Gray1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>PC</given-names></name><name><surname>Harrison</surname><given-names>CA</given-names></name><name><surname>Vale</surname><given-names>W</given-names></name></person-group><article-title>
<italic>Cripto</italic> forms a complex with activin and type II activin receptors and can block activin signaling</article-title><source>Proc Natl Acad Sci U S A</source><year>2003</year><volume>100</volume><fpage>5193</fpage><lpage>5198</lpage><pub-id pub-id-type="pmid">12682303</pub-id></element-citation></ref><ref id="pbio-0020030-Greenwald1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenwald</surname><given-names>J</given-names></name><name><surname>Groppe</surname><given-names>J</given-names></name><name><surname>Gray</surname><given-names>P</given-names></name><name><surname>Wiater</surname><given-names>E</given-names></name><name><surname>Kwiatkowski</surname><given-names>W</given-names></name><etal/></person-group><article-title>The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly</article-title><source>Mol Cell</source><year>2003</year><volume>11</volume><fpage>605</fpage><lpage>617</lpage><pub-id pub-id-type="pmid">12667445</pub-id></element-citation></ref><ref id="pbio-0020030-Gritsman1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gritsman</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>S</given-names></name><name><surname>Heckscher</surname><given-names>E</given-names></name><name><surname>Talbot</surname><given-names>WS</given-names></name><etal/></person-group><article-title>The EGF-CFC protein One-eyed pinhead is essential for <italic>nodal</italic> signaling</article-title><source>Cell</source><year>1999</year><volume>97</volume><fpage>121</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">10199408</pub-id></element-citation></ref><ref id="pbio-0020030-Hamada1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamada</surname><given-names>H</given-names></name><name><surname>Meno</surname><given-names>C</given-names></name><name><surname>Watanabe</surname><given-names>D</given-names></name><name><surname>Saijoh</surname><given-names>Y</given-names></name></person-group><article-title>Establishment of vertebrate left&#x02013;right asymmetry</article-title><source>Nat Rev Genet</source><year>2002</year><volume>3</volume><fpage>103</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">11836504</pub-id></element-citation></ref><ref id="pbio-0020030-Helde1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helde</surname><given-names>KA</given-names></name><name><surname>Grunwald</surname><given-names>DJ</given-names></name></person-group><article-title>The DVR-1 (Vg1) transcript of zebrafish is maternally supplied and distributed throughout the embryo</article-title><source>Dev Biol</source><year>1993</year><volume>159</volume><fpage>418</fpage><lpage>426</lpage><pub-id pub-id-type="pmid">8405668</pub-id></element-citation></ref><ref id="pbio-0020030-Hemmati-Brivanlou1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemmati-Brivanlou</surname><given-names>A</given-names></name><name><surname>Melton</surname><given-names>DA</given-names></name></person-group><article-title>A truncated activin receptor inhibits mesoderm induction and formation of axial structures in <italic>Xenopus</italic> embryos</article-title><source>Nature</source><year>1992</year><volume>359</volume><fpage>609</fpage><lpage>614</lpage><pub-id pub-id-type="pmid">1328888</pub-id></element-citation></ref><ref id="pbio-0020030-Hemmati-Brivanlou2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemmati-Brivanlou</surname><given-names>A</given-names></name><name><surname>Wright</surname><given-names>DA</given-names></name><name><surname>Melton</surname><given-names>DA</given-names></name></person-group><article-title>Embryonic expression and functional analysis of a <italic>Xenopus</italic> activin receptor</article-title><source>Dev Dyn</source><year>1992</year><volume>194</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">1384808</pub-id></element-citation></ref><ref id="pbio-0020030-Ishimaru1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishimaru</surname><given-names>Y</given-names></name><name><surname>Yoshioka</surname><given-names>H</given-names></name><name><surname>Tao</surname><given-names>H</given-names></name><name><surname>Thisse</surname><given-names>B</given-names></name><name><surname>Thisse</surname><given-names>C</given-names></name><etal/></person-group><article-title>Asymmetric expression of <italic>antivin/lefty1</italic> in the early chick embryo</article-title><source>Mech Dev</source><year>2000</year><volume>90</volume><fpage>115</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">10585569</pub-id></element-citation></ref><ref id="pbio-0020030-Kirsch1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirsch</surname><given-names>T</given-names></name><name><surname>Nickel</surname><given-names>J</given-names></name><name><surname>Sebald</surname><given-names>W</given-names></name></person-group><article-title>BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II</article-title><source>EMBO J</source><year>2000</year><volume>19</volume><fpage>3314</fpage><lpage>3324</lpage><pub-id pub-id-type="pmid">10880444</pub-id></element-citation></ref><ref id="pbio-0020030-Long1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>S</given-names></name><name><surname>Ahmad</surname><given-names>N</given-names></name><name><surname>Rebagliati</surname><given-names>M</given-names></name></person-group><article-title>The zebrafish <italic>nodal</italic>-related gene s<italic>outhpaw</italic> is required for visceral and diencephalic left&#x02013;right asymmetry</article-title><source>Development</source><year>2003</year><volume>130</volume><fpage>2303</fpage><lpage>2316</lpage><pub-id pub-id-type="pmid">12702646</pub-id></element-citation></ref><ref id="pbio-0020030-Mathews1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathews</surname><given-names>LS</given-names></name><name><surname>Vale</surname><given-names>WW</given-names></name></person-group><article-title>Expression cloning of an activin receptor, a predicted transmembrane serine kinase</article-title><source>Cell</source><year>1991</year><volume>65</volume><fpage>973</fpage><lpage>982</lpage><pub-id pub-id-type="pmid">1646080</pub-id></element-citation></ref><ref id="pbio-0020030-Mathews2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathews</surname><given-names>LS</given-names></name><name><surname>Vale</surname><given-names>WW</given-names></name><name><surname>Kintner</surname><given-names>CR</given-names></name></person-group><article-title>Cloning of a second type of activin receptor and functional characterization in <italic>Xenopus</italic> embryos</article-title><source>Science</source><year>1992</year><volume>255</volume><fpage>1702</fpage><lpage>1705</lpage><pub-id pub-id-type="pmid">1313188</pub-id></element-citation></ref><ref id="pbio-0020030-Meno1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meno</surname><given-names>C</given-names></name><name><surname>Saijoh</surname><given-names>Y</given-names></name><name><surname>Fujii</surname><given-names>H</given-names></name><name><surname>Ikeda</surname><given-names>M</given-names></name><name><surname>Yokoyama</surname><given-names>T</given-names></name><etal/></person-group><article-title>Left&#x02013;right asymmetric expression of the TGF beta-family member <italic>lefty</italic> in mouse embryos</article-title><source>Nature</source><year>1996</year><volume>381</volume><fpage>151</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">8610011</pub-id></element-citation></ref><ref id="pbio-0020030-Meno2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meno</surname><given-names>C</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><name><surname>Saijoh</surname><given-names>Y</given-names></name><name><surname>Matsuda</surname><given-names>Y</given-names></name><name><surname>Tashiro</surname><given-names>K</given-names></name><etal/></person-group><article-title>Two closely-related left&#x02013;right asymmetrically expressed genes, <italic>lefty-1</italic> and <italic>lefty-2</italic>: Their distinct expression domains, chromosomal linkage and direct neuralizing activity in <italic>Xenopus</italic> embryos</article-title><source>Genes Cells</source><year>1997</year><volume>2</volume><fpage>513</fpage><lpage>524</lpage><pub-id pub-id-type="pmid">9348041</pub-id></element-citation></ref><ref id="pbio-0020030-Meno3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meno</surname><given-names>C</given-names></name><name><surname>Shimono</surname><given-names>A</given-names></name><name><surname>Saijoh</surname><given-names>Y</given-names></name><name><surname>Yashiro</surname><given-names>K</given-names></name><name><surname>Mochida</surname><given-names>K</given-names></name><etal/></person-group><article-title>
<italic>lefty-1</italic> is required for left&#x02013;right determination as a regulator of <italic>lefty-2</italic> and <italic>nodal</italic>
</article-title><source>Cell</source><year>1998</year><volume>94</volume><fpage>287</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">9708731</pub-id></element-citation></ref><ref id="pbio-0020030-Meno4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meno</surname><given-names>C</given-names></name><name><surname>Gritsman</surname><given-names>K</given-names></name><name><surname>Ohishi</surname><given-names>S</given-names></name><name><surname>Ohfuji</surname><given-names>Y</given-names></name><name><surname>Heckscher</surname><given-names>E</given-names></name><etal/></person-group><article-title>Mouse Lefty2 and zebrafish antivin are feedback inhibitors of <italic>nodal</italic> signaling during vertebrate gastrulation</article-title><source>Mol Cell</source><year>1999</year><volume>4</volume><fpage>287</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">10518210</pub-id></element-citation></ref><ref id="pbio-0020030-Meno5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meno</surname><given-names>C</given-names></name><name><surname>Takeuchi</surname><given-names>J</given-names></name><name><surname>Sakuma</surname><given-names>R</given-names></name><name><surname>Koshiba-Takeuchi</surname><given-names>K</given-names></name><name><surname>Ohishi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Diffusion of <italic>nodal</italic> signaling activity in the absence of the feedback inhibitor Lefty2</article-title><source>Dev Cell</source><year>2001</year><volume>1</volume><fpage>127</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">11703930</pub-id></element-citation></ref><ref id="pbio-0020030-Minchiotti1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minchiotti</surname><given-names>G</given-names></name><name><surname>Parisi</surname><given-names>S</given-names></name><name><surname>Liguori</surname><given-names>GL</given-names></name><name><surname>D'Andrea</surname><given-names>D</given-names></name><name><surname>Persico</surname><given-names>MG</given-names></name></person-group><article-title>Role of the EGF-CFC gene <italic>cripto</italic> in cell differentiation and embryo development</article-title><source>Gene</source><year>2002</year><volume>287</volume><fpage>33</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">11992720</pub-id></element-citation></ref><ref id="pbio-0020030-Piek1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piek</surname><given-names>E</given-names></name><name><surname>Heldin</surname><given-names>CH</given-names></name><name><surname>ten Dijke</surname><given-names>P</given-names></name></person-group><article-title>Specificity, diversity, and regulation in TGF-beta superfamily signaling</article-title><source>FASEB J</source><year>1999</year><volume>13</volume><fpage>2105</fpage><lpage>2124</lpage><pub-id pub-id-type="pmid">10593858</pub-id></element-citation></ref><ref id="pbio-0020030-Rankin1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rankin</surname><given-names>CT</given-names></name><name><surname>Bunton</surname><given-names>T</given-names></name><name><surname>Lawler</surname><given-names>AM</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name></person-group><article-title>Regulation of left&#x02013;right patterning in mice by growth/differentiation factor-1</article-title><source>Nat Genet</source><year>2000</year><volume>24</volume><fpage>262</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">10700179</pub-id></element-citation></ref><ref id="pbio-0020030-Reissmann1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reissmann</surname><given-names>E</given-names></name><name><surname>Jornvall</surname><given-names>H</given-names></name><name><surname>Blokzijl</surname><given-names>A</given-names></name><name><surname>Andersson</surname><given-names>O</given-names></name><name><surname>Chang</surname><given-names>C</given-names></name><etal/></person-group><article-title>The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development</article-title><source>Genes Dev</source><year>2001</year><volume>15</volume><fpage>2010</fpage><lpage>2022</lpage><pub-id pub-id-type="pmid">11485994</pub-id></element-citation></ref><ref id="pbio-0020030-Sakuma1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakuma</surname><given-names>R</given-names></name><name><surname>Ohnishi</surname><given-names>Y-I</given-names></name><name><surname>Meno</surname><given-names>C</given-names></name><name><surname>Fujii</surname><given-names>H</given-names></name><name><surname>Juan</surname><given-names>H</given-names></name><etal/></person-group><article-title>Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion</article-title><source>Genes Cells</source><year>2002</year><volume>7</volume><fpage>401</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">11952836</pub-id></element-citation></ref><ref id="pbio-0020030-Salomon1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salomon</surname><given-names>DS</given-names></name><name><surname>Bianco</surname><given-names>C</given-names></name><name><surname>Ebert</surname><given-names>AD</given-names></name><name><surname>Khan</surname><given-names>NI</given-names></name><name><surname>De Santis</surname><given-names>M</given-names></name><etal/></person-group><article-title>The EGF-CFC family: Novel epidermal growth factor-related proteins in development and cancer</article-title><source>Endocr Relat Cancer</source><year>2000</year><volume>7</volume><fpage>199</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">11174844</pub-id></element-citation></ref><ref id="pbio-0020030-Schier1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><article-title>Nodal signaling in vertebrate development</article-title><source>Annu Rev Cell Dev Biol</source><year>2003</year><volume>19</volume><fpage>589</fpage><lpage>621</lpage><pub-id pub-id-type="pmid">14570583</pub-id></element-citation></ref><ref id="pbio-0020030-Schier2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schier</surname><given-names>AF</given-names></name><name><surname>Shen</surname><given-names>MM</given-names></name></person-group><article-title>Nodal signalling in vertebrate development</article-title><source>Nature</source><year>2000</year><volume>403</volume><fpage>385</fpage><lpage>389</lpage><pub-id pub-id-type="pmid">10667782</pub-id></element-citation></ref><ref id="pbio-0020030-Schulte-Merker1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulte-Merker</surname><given-names>S</given-names></name><name><surname>Hammerschmidt</surname><given-names>M</given-names></name><name><surname>Beuchle</surname><given-names>D</given-names></name><name><surname>Cho</surname><given-names>KW</given-names></name><name><surname>De Robertis</surname><given-names>EM</given-names></name><etal/></person-group><article-title>Expression of zebrafish <italic>goosecoid</italic> and <italic>no tail</italic> gene products in wild-type and mutant <italic>no tail</italic> embryos</article-title><source>Development</source><year>1994</year><volume>120</volume><fpage>843</fpage><lpage>852</lpage><pub-id pub-id-type="pmid">7600961</pub-id></element-citation></ref><ref id="pbio-0020030-Shen1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>MM</given-names></name></person-group><article-title>Decrypting the role of Cripto in tumorigenesis</article-title><source>J Clin Invest</source><year>2003</year><volume>112</volume><fpage>500</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">12925690</pub-id></element-citation></ref><ref id="pbio-0020030-Shen2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>MM</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><article-title>The EGF-CFC gene family in vertebrate development</article-title><source>Trends Genet</source><year>2000</year><volume>16</volume><fpage>303</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">10858660</pub-id></element-citation></ref><ref id="pbio-0020030-Shen3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>MM</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Leder</surname><given-names>P</given-names></name></person-group><article-title>A differential display strategy identifies <italic>Cryptic</italic>, a novel EGF-related gene expressed in the axial and lateral mesoderm during mouse gastrulation</article-title><source>Development</source><year>1997</year><volume>124</volume><fpage>429</fpage><lpage>442</lpage><pub-id pub-id-type="pmid">9053319</pub-id></element-citation></ref><ref id="pbio-0020030-Shi1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Massague</surname><given-names>J</given-names></name></person-group><article-title>Mechanisms of TGF-beta signaling from cell membrane to the nucleus</article-title><source>Cell</source><year>2003</year><volume>113</volume><fpage>685</fpage><lpage>700</lpage><pub-id pub-id-type="pmid">12809600</pub-id></element-citation></ref><ref id="pbio-0020030-Smith1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>JC</given-names></name><name><surname>Price</surname><given-names>BM</given-names></name><name><surname>Van Nimmen</surname><given-names>K</given-names></name><name><surname>Huylebroeck</surname><given-names>D</given-names></name></person-group><article-title>Identification of a potent <italic>Xenopus</italic> mesoderm-inducing factor as a homologue of activin A</article-title><source>Nature</source><year>1990</year><volume>345</volume><fpage>729</fpage><lpage>731</lpage><pub-id pub-id-type="pmid">2113615</pub-id></element-citation></ref><ref id="pbio-0020030-Stachel1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stachel</surname><given-names>SE</given-names></name><name><surname>Grunwald</surname><given-names>DJ</given-names></name><name><surname>Myers</surname><given-names>PZ</given-names></name></person-group><article-title>Lithium perturbation and <italic>goosecoid</italic> expression identify a dorsal specification pathway in the pregastrula zebrafish</article-title><source>Development</source><year>1993</year><volume>117</volume><fpage>1261</fpage><lpage>1274</lpage><pub-id pub-id-type="pmid">8104775</pub-id></element-citation></ref><ref id="pbio-0020030-Tanegashima1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanegashima</surname><given-names>K</given-names></name><name><surname>Yokota</surname><given-names>C</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Asashima</surname><given-names>M</given-names></name></person-group><article-title>Expression cloning of <italic>Xantivin</italic>, a <italic>Xenopus lefty/antivin</italic>-related gene, involved in the regulation of activin signaling during mesoderm induction</article-title><source>Mech Dev</source><year>2000</year><volume>99</volume><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">11091069</pub-id></element-citation></ref><ref id="pbio-0020030-ten1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ten Dijke</surname><given-names>P</given-names></name><name><surname>Yamashita</surname><given-names>H</given-names></name><name><surname>Ichijo</surname><given-names>H</given-names></name><name><surname>Franzen</surname><given-names>P</given-names></name><name><surname>Laiho</surname><given-names>M</given-names></name><etal/></person-group><article-title>Characterization of type I receptors for transforming growth factor-beta and activin</article-title><source>Science</source><year>1994</year><volume>264</volume><fpage>101</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">8140412</pub-id></element-citation></ref><ref id="pbio-0020030-Thisse1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thisse</surname><given-names>C</given-names></name><name><surname>Thisse</surname><given-names>B</given-names></name></person-group><article-title>Antivin, a novel and divergent member of the TGF&#x003b2; superfamily, negatively regulates mesoderm induction</article-title><source>Development</source><year>1999</year><volume>126</volume><fpage>229</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">9847237</pub-id></element-citation></ref><ref id="pbio-0020030-Thisse2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thisse</surname><given-names>C</given-names></name><name><surname>Thisse</surname><given-names>B</given-names></name><name><surname>Schilling</surname><given-names>TF</given-names></name><name><surname>Postlethwait</surname><given-names>JH</given-names></name></person-group><article-title>Structure of the zebrafish <italic>snail1</italic> gene and its expression in wild-type, <italic>spadetail</italic> and <italic>no tail</italic> mutant embryos</article-title><source>Development</source><year>1993</year><volume>119</volume><fpage>1203</fpage><lpage>1215</lpage><pub-id pub-id-type="pmid">8306883</pub-id></element-citation></ref><ref id="pbio-0020030-Thisse3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thisse</surname><given-names>B</given-names></name><name><surname>Wright</surname><given-names>CV</given-names></name><name><surname>Thisse</surname><given-names>C</given-names></name></person-group><article-title>Activin- and Nodal-related factors control antero-posterior patterning of the zebrafish embryo</article-title><source>Nature</source><year>2000</year><volume>403</volume><fpage>425</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">10667793</pub-id></element-citation></ref><ref id="pbio-0020030-Thompson1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>TB</given-names></name><name><surname>Woodruff</surname><given-names>TK</given-names></name><name><surname>Jardetzky</surname><given-names>TS</given-names></name></person-group><article-title>Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions</article-title><source>EMBO J</source><year>2003</year><volume>22</volume><fpage>1555</fpage><lpage>1566</lpage><pub-id pub-id-type="pmid">12660162</pub-id></element-citation></ref><ref id="pbio-0020030-Thomsen1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomsen</surname><given-names>G</given-names></name><name><surname>Woolf</surname><given-names>T</given-names></name><name><surname>Whitman</surname><given-names>M</given-names></name><name><surname>Sokol</surname><given-names>S</given-names></name><name><surname>Vaughan</surname><given-names>J</given-names></name><etal/></person-group><article-title>Activins are expressed early in <italic>Xenopus</italic> embryogenesis and can induce axial mesoderm and anterior structures</article-title><source>Cell</source><year>1990</year><volume>63</volume><fpage>485</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">2225062</pub-id></element-citation></ref><ref id="pbio-0020030-Toyama1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyama</surname><given-names>R</given-names></name><name><surname>O'Connell</surname><given-names>ML</given-names></name><name><surname>Wright</surname><given-names>CV</given-names></name><name><surname>Kuehn</surname><given-names>MR</given-names></name><name><surname>Dawid</surname><given-names>IB</given-names></name></person-group><article-title>Nodal induces ectopic <italic>goosecoid</italic> and <italic>lim1</italic> expression and axis duplication in zebrafish</article-title><source>Development</source><year>1995</year><volume>121</volume><fpage>383</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">7768180</pub-id></element-citation></ref><ref id="pbio-0020030-van1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Eijnden-Van Raaij</surname><given-names>AJ</given-names></name><name><surname>van Zoelent</surname><given-names>EJ</given-names></name><name><surname>van Nimmen</surname><given-names>K</given-names></name><name><surname>Koster</surname><given-names>CH</given-names></name><name><surname>Snoek</surname><given-names>GT</given-names></name><etal/></person-group><article-title>Activin-like factor from a <named-content content-type="genus-species">Xenopus laevis</named-content> cell line responsible for mesoderm induction</article-title><source>Nature</source><year>1990</year><volume>345</volume><fpage>732</fpage><lpage>734</lpage><pub-id pub-id-type="pmid">2113616</pub-id></element-citation></ref><ref id="pbio-0020030-Wuytens1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wuytens</surname><given-names>G</given-names></name><name><surname>Verschueren</surname><given-names>K</given-names></name><name><surname>de Winter</surname><given-names>JP</given-names></name><name><surname>Gajendran</surname><given-names>N</given-names></name><name><surname>Beek</surname><given-names>L</given-names></name><etal/></person-group><article-title>Identification of two amino acids in activin A that are important for biological activity and binding to the activin type II receptors</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>9821</fpage><lpage>9827</lpage><pub-id pub-id-type="pmid">10092672</pub-id></element-citation></ref><ref id="pbio-0020030-Yan1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>YT</given-names></name><name><surname>Gritsman</surname><given-names>K</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Burdine</surname><given-names>RD</given-names></name><name><surname>Corrales</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Conserved requirement for EGF-CFC genes in vertebrate left&#x02013;right axis formation</article-title><source>Genes Dev</source><year>1999</year><volume>13</volume><fpage>2527</fpage><lpage>2537</lpage><pub-id pub-id-type="pmid">10521397</pub-id></element-citation></ref><ref id="pbio-0020030-Yan2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>YT</given-names></name><name><surname>Liu</surname><given-names>JJ</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Chaosu</surname><given-names>E</given-names></name><name><surname>Haltiwanger</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Dual roles of Cripto as a ligand and coreceptor in the <italic>nodal</italic> signaling pathway</article-title><source>Mol Cell Biol</source><year>2002</year><volume>22</volume><fpage>4439</fpage><lpage>4449</lpage><pub-id pub-id-type="pmid">12052855</pub-id></element-citation></ref><ref id="pbio-0020030-Yeo1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeo</surname><given-names>C</given-names></name><name><surname>Whitman</surname><given-names>M</given-names></name></person-group><article-title>Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms</article-title><source>Mol Cell</source><year>2001</year><volume>7</volume><fpage>949</fpage><lpage>957</lpage><pub-id pub-id-type="pmid">11389842</pub-id></element-citation></ref><ref id="pbio-0020030-Zhang1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Talbot</surname><given-names>WS</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><article-title>Positional cloning identifies zebrafish <italic>one-eyed pinhead</italic> as a permissive EGF-related ligand required during gastrulation</article-title><source>Cell</source><year>1998</year><volume>92</volume><fpage>241</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">9458048</pub-id></element-citation></ref><ref id="pbio-0020030-Zhou1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Sasaki</surname><given-names>H</given-names></name><name><surname>Lowe</surname><given-names>L</given-names></name><name><surname>Hogan</surname><given-names>BL</given-names></name><name><surname>Kuehn</surname><given-names>MR</given-names></name></person-group><article-title>Nodal is a novel TGF-beta-like gene expressed in the mouse node during gastrulation</article-title><source>Nature</source><year>1993</year><volume>361</volume><fpage>543</fpage><lpage>547</lpage><pub-id pub-id-type="pmid">8429908</pub-id></element-citation></ref></ref-list><glossary><title>Abbreviations</title><def-list><def-item><term>Act&#x003b2;A</term><def><p>Activin&#x003b2;A</p></def></def-item><def-item><term>Act&#x003b2;B</term><def><p>Activin&#x003b2;B</p></def></def-item><def-item><term>ActRIIB</term><def><p>Activin receptor type IIB</p></def></def-item><def-item><term>Alk4</term><def><p>Activin receptor-like kinase-4</p></def></def-item><def-item><term>DTSSP</term><def><p>3,3&#x02032;-dithiobis(sulfo-succinimidyl propionate)</p></def></def-item><def-item><term>EGF-CFC</term><def><p>epidermal growth factor&#x02013;Cripto/FRL-1/Cryptic</p></def></def-item><def-item><term>GDF1</term><def><p>growth and differentiation factor-1</p></def></def-item><def-item><term><italic>gsc</italic></term><def><p>
<italic>goosecoid</italic>
</p></def></def-item><def-item><term>GPI</term><def><p>glycosylphosphatidylinositol</p></def></def-item><def-item><term>HA</term><def><p>hemagglutinin</p></def></def-item><def-item><term>hpf</term><def><p>hours postfertilization</p></def></def-item><def-item><term>kDa</term><def><p>kilodalton</p></def></def-item><def-item><term><italic>LacZ</italic></term><def><p>
<named-content content-type="genus-species">E. coli</named-content> &#x003b2;-galactosidease</p></def></def-item><def-item><term>luc</term><def><p>luciferase</p></def></def-item><def-item><term>MAPK</term><def><p>mitogen-activated protein kinase</p></def></def-item><def-item><term>MZ<italic>oep</italic></term><def><p>maternal- and zygotic-deficient mutant of <italic>oep</italic>
</p></def></def-item><def-item><term><italic>ntl</italic></term><def><p>
<italic>no tail</italic>
</p></def></def-item><def-item><term><italic>oep</italic></term><def><p>
<italic>one-eyed pinhead</italic>
</p></def></def-item><def-item><term><italic>sqt</italic></term><def><p>
<italic>squint</italic>
</p></def></def-item><def-item><term>TGF&#x003b2;</term><def><p>transforming growth factor-&#x003b2;</p></def></def-item><def-item><term>VEGF-D</term><def><p>vascular endothelial growth factor-D</p></def></def-item></def-list></glossary></back></article>